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Abstract  
Postoperative total knee arthroplasty (TKA) pain is severe and can inhibit patients’
rehabilitation. We devised a single injection motor sparing knee block (MSB) by targeting
the adductor canal and lateral femoral cutaneous nerve with a posterior knee infiltration
under ultrasound. Our primary objective was to evaluate the duration of the MSB compared
to a standard periarticular infiltration (PAI) using time to first rescue analgesia as the end
point. We randomized 82 patients undergoing TKA to receive either preoperative MSB or
intraoperative periarticular infiltration. Duration of analgesia was significantly longer in the
MSB group with a mean difference of 8.8 hours. No significant differences were found in
quadriceps strength, functional outcomes, side effects, satisfaction, or length of stay between
groups. The MSB provided longer analgesia than the PAI while not negatively affecting
quadriceps strength, length of stay, or functional rehabilitation.

Keywords
Total knee arthroplasty, motor sparing, nerve block, adductor canal block, periarticular
infiltration
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Chapter  1    

1  

Introduction  

The total knee arthroplasty (TKA) is a highly successful procedure for treating patients with
advanced osteoarthritis (OA)1. The number of knee replacement surgeries has risen over the
past decade and is projected to increase 6-fold from 2005 to 2030 because of the aging
population2. Severe acute postoperative pain may interfere with patients’ ability to sleep,
walk, and participate in rehabilitation activites3.
Traditionally, analgesia techniques such as patient-controlled analgesia (PCA), continuous
epidural analgesia (CEA), lumbar plexus block (LPB), and femoral nerve blocks (FNB)
have been performed to reduce pain during the immediate postoperative period. PCA using
intravenous opioids and continuous epidurals pose the risk of side effects such as; nausea,
pruritus, vomiting, dizziness, urinary retention, sedation, poor muscle control, and
constipation4–7. LPBs require advanced skills and FNBs cause quadriceps weakness that
increase the risk of inpatient falls8–10.
It is important to preserve quadriceps strength in the immediate postoperative period,
leading to early mobilization after surgery and enhancing functional recovery. Recently,
adductor canal blocks (ACB) and periarticular infiltrations (PAI) have become popular
because they are able to preserve quadriceps strength while providing similar postoperative
analgesia to the traditional FNB3,11–15. One drawback to ACBs is that they do not provide
analgesia to the posterior knee. Single injection PAIs performed at the end of surgery can
have a shorter duration of analgesia15. Although continuous infusions prolong postoperative
pain relief, the potential risk of joint infections caused by the catheter used to administer the
infusion is an impediment to its popularity 5,16.
We have developed a motor sparing knee block (MSB) for providing regional analgesia that
minimally interferes with quadriceps innervation following TKA. Further, the MSB involves
a combination of the single injection ACB with the addition of posterior knee infiltration
and blockage of the lateral cutaneous nerve. Our clinical trial is the first to investigate
whether there are any differences in duration of analgesia, quadriceps strength, function,
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pain, satisfaction, side effects, and length of stay between the MSB and PAI techniques
following TKA. We believe the MSB can serve as an attractive alternative regional block
technique for patients undergoing TKA.
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Chapter  2    

2  
2.1  

Literature  Review  
Anatomy  of  The  Knee  Joint  

2.1.1  Bony  Structures  
The knee is one of the largest and most complex joints in the body consisting of three
bones; the femur, tibia, fibula, and patella17. The distal femur is asymmetrical allowing
for attachment of various ligaments and tendons. The convex eminence of the medial
epicondyle serves as the attachment point for the medial collateral ligament. The lateral
epicondyle of the femur serves as the femoral attachment for the lateral collateral
ligament. The epicondylar axis in normal knees is defined as the line that passes from the
sulcus of the medial epicondyle to the prominence of the lateral epicondyle18.
The tibia also consists of medial and lateral condyles and articulates with the distal
femur. The prominent aspect of the tibia has a spine, which has an anterior depression
that serves as attachments for the anterior horns of the medial and lateral menisci and
anterior cruciate ligament (ACL)17. Anteriorly, the tibia has a tubercle that functions as
the insertion point for the patella tendon. The Gerdy’s tubercle is located three
centimeters laterally from this and is the insertion site for the iliotibial band (ITB)18. The
fibula is a leg bone located laterally to the tibia. The head of the fibula forms the
proximal tibiofibular joint with the lateral edge of the tibia. At its distal end, the fibula
forms a lateral malleolus. At the medial malleolus of the tibia, the fibula forms the distal
tibiofibular joint. Finally, the patella articulates with the trochlea of the distal femur17.
The patella functions to protect the front of the knee and increase leverage through the
range of knee extension19.
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Figure 1: Structures of the knee joint
Reprinted with permission from theodora.com/anatomy

2.1.2   Muscles  
The anterior aspect of the upper leg consists of four muscles collectively called the
quadriceps that function to extend the knee joint18. The rectus femoris muscle originates
proximally from the ilium forming a muscle belly in the anterior thigh. It then narrows
into a tendon above the patella. The largest muscle of the quadriceps group, the vastus
lateralis originates from the proximal intertrochanteric line of the femur extending
halfway down the linea aspera17. The vastus lateralis ultimately inserts into the tibia. The
vastus medialis, which is sometimes divided into the vastus medialis obliquus (VMO)
and the vastus medialis longus (VML) originates from the intertrochanteric line and
inserts with the other muscles of the quadriceps in the quadriceps tendon18. Lastly, the
vastus intermedius originates at the lateral and anterior aspect of the femur. Its fibers also
end in the quadriceps tendon. Overall, the rectus femoris forms the most superficial
layer of the quadriceps tendon. The vastus medialis and vastus lateralis contribute to the
middle later, and the insertion of the intermedius forms the deepest layer17. After forming
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the quadriceps tendon, these four insertions become the patellar tendon, which inserts at
the tibial tubercle18.
The sartorius, gracilis, semitendinosus, semimembranosus, and medial head of the
gastrocnemius are all located at the medial side of the knee17. Collectively the
semimembranosus, semitendinosus, and bicep femoris make up the posterior hamstring
thigh muscles that function in knee flexion. Known as the pes anserinus muscles, the
sartorius, gracilis, and semimembranosus muscles flex and internally rotate the knee18.
The lateral side of the knee contains the iliiotibial band (ITB), biceps femoris, popliteus,
and lateral gastrocnemius muscles19.

2.1.3  

Menisci  

The menisci are two crescent-shaped fibro-cartilaginous structures functioning to deepen
the tibial surface for the articulation of the distal femur19. Their circumferential pattern
aids in absorbing the compressive load on the knee. Each meniscus covers approximately
two-thirds of the matching articular surface of the tibia18. The medial meniscus is
semicircular shaped and is broader posteriorly. The lateral meniscus is almost completely
circular allowing it to cover a larger surface area. The menisci serve many functions such
as aiding in load transmission by increasing the contact area, distribution of synovial
fluid, enhancement of articular conformity, and prevention of soft tissue impingement
during motion17.

2.1.4  

Ligaments  

The knee joint consists of four ligaments that provide stability to the knee. The anterior
cruciate ligament (ACL) is the primary static stabilizer of the knee and prevents the tibia
from shifting anteriorly to the femur. The ACL originates from the medial aspect of the
femoral condyle at the posterior aspect of the intercondylar notch and travels in an
anterior, distal, and medial direction toward the tibia18. The posterior cruciate ligament
(PCL) functions to prevent the tibia from shifting posteriorly relative to the femur. It
provides approximately 95% of the total restraint to posterior translation of the tibia on
the femur17. The PCL originates posteriorly in the intercondylar notch of the medial
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femoral condyle and attaches to the posterior intercondyloid fossa of the tibia18.The
medial collateral ligament (MCL) is a broad flat membranous band originating from the
medial epicondyle of the femur and runs to the medial condyle of the tibia. It functions to
resist forces that would push the knee medially preventing valgus deformity. More
narrow than the MCL, the lateral collateral ligament (LCL) originates from the lateral
epicondyle of the femur above and travels to the head of the fibula below17. It also
functions in maintaining knee stability as it moves through its full arc of motion19.

2.1.5  

Nerve  anatomy  of  the  lower  limb  

The nerves of the leg and foot arise from the lumbar and sacral roots arising from the
spinal cord in the lower back and pelvis. These roots form two networks of crossed
nerves called the lumbar plexus and sacral plexus18. The femoral, saphenous, obturator,
and lateral femoral cutaneous nerves all extend from the lumbar plexus into the muscles
and skin of the lower limb17. Innervation of the knee joint can be divided by location. The
femoral nerve provides anterior and medial innervation to the knee18. Branches of the
femoral nerve innervate the quadriceps muscles and skin of the anterior and medial thigh.
Its largest branch the saphenous nerve, extends this innervation to the skin of the medial
lower leg and foot17,20. The lateral femoral cutaneous nerve supplies the skin on the
lateral region of the thigh.
The saphenous nerve is the largest cutaneous branch of the femoral nerve and begins
from the distal division of the femoral nerve8,11,17. At the distal end of the adductor canal
it penetrates the deep fascia on the medial area of the knee situated between the sartorius
and gracilis tendons. The saphenous nerve divides into two branches; the infrapatellar
branch of the saphenous nerve follows the sartorius muscle and innervates the
anteromedial capsule, skin of the knee, and the patellar tendon18. The sartorial branch
travels further distally and innervates the medial area of the lower leg and ankle11.
The tibial nerve and obturator nerve function in posterior knee and medial thigh
innervation respectively18. Branching from the long sciatic nerve originating from the
sacral plexus, the tibial nerve begins in the distal posterior aspect of the thigh17. Running
distally though the popliteal fossa, the tibial nerve continues between the two heads of the
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gastrocnemius. The medial sural cutaneous nerve is a branch of the tibial nerve that
travels on the surface of the gastrocnemius17. The largest articular branch of the tibial
nerve, the posterior articular nerve arises within the popliteal fossa and then joins the
popliteal plexus laterally.
Finally, the common peroneal (or fibular nerve) enters the popliteal fossa lateral to the
tibial nerve and continues distally along the medial side of the biceps femoris tendon. It
branches into the lateral sural cutaneous nerve. It continues between the biceps femoris
tendon and the lateral head of the gastrocnemius. Distally it travels superficially across
the lateral aspect of the fibular neck before dividing into the superficial and deep peroneal
nerves18.

Figure 2: Nerves and Muscles of the Upper Leg
Reprinted with permission from
http://www.daviddarling.info/encyclopedia/F/femoral_nerve.html
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2.1.6  

Blood  Supply  

The adductor canal also known as the Hunter’s canal or sub-sartorial canal, is an
aponeurotic tunnel in the medial aspect of the upper leg8,11,17,21. This canal extends from
the beginning of the femoral triangle to the adductor haitus and contains the femoral
artery, femoral vein, and branches of the femoral nerve. Coursing between the anterior
and medial component of the thigh, the adductor canal is bounded anteriorly by the
sartorius, postermedially by the adductor longus and magnus, and laterally by the vastus
medialis muscle17,18.The femoral artery is the primary arterial supply to the lower limb. It
descends from the femoral triangle and through the adductor canal. Before passing
through the adductor haitus the femoral artery becomes the descending genicular artery,
which splits into two branches17. The first branch is the saphenous branch, which
accompanies the saphenous nerve to the medial side of the knee. The saphenous branch
travels between the sartorius and the gracilis muscles before combining into the medial
inferior genicular artery17,18. Secondly, the articular branch of the descending genicular
artery passes through the vastus medialis and then forms an anastomosis with the medial
superior genicular artery and anterior recurrent tibial artery17.
The popliteal artery is a continuation of the femoral artery after it exits the adductor canal
and before it enters the popliteal fossa18. It descends superficially to the popliteus fascia
and then separates at the lower border of the popliteus into the anterior and posterior
tibial arteries. Around the knee the popliteal artery divides into many muscular branches
and specifically five genicular branches; the medial superior, lateral superior, middle,
medial inferior, and lateral inferior17. All of these genicular branches supply blood to the
peripheral third of the menisci, however a majority of the blood comes from the superior
and inferior lateral geniculates18. Finally, the middle genicular artery forms branches that
enter the synovium and form a plexus that covers the ACL and PCL. These branches
anastomose with vessels that run parallel to the collagen fibers.
The anterior anastomosis of the knee joint connects the circulation of femoral artery with
popliteal and anterior tibial arteries17. It is formed by the two medial genicular branches,
the two lateral genicular branches, the descending genicular branch, the descending
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branch of the lateral femoral circumflex, and the anterior recurrent tibial artery17,18.
Collectively, these vessels surround the patella and then split into nutrient vessels at the
inferior pole of the patella that ascend proximally on the anterior surface of the bone.
The skin of the anterior knee receives blood from both the medial and lateral side,
however the primary vascular supply comes from the medial side18.

2.2   Osteoarthritis  
Arthritis is an umbrella term used to describe more than 100 diseases and conditions that
affect the joints causing pain, swelling, and stiffness which often lead to disability19. It is
one of the most prevalent chronic health conditions in Canada and is the second and third
most common chronic conditions reported by women and men respectively22. As the
most common form of arthritis, osteoarthritis (OA) also known as degenerative arthritis
or degenerative joint disease, is caused by a group of mechanisms that result in the
deterioration of joint cartilage and thickening of the bones underneath in one or more
joints23,24. According to the World Health Organization (WHO), 9.6% of men and 18% of
women older than 60 years of age worldwide have symptomatic OA, making this
condition one of the most prevalent chronic conditions25. In Canada, one in ten adults are
affected with OA26. As the disease progresses, joint damage, pain, and stiffness manifest
with the knee being the most common joint involved27. Exact causes of OA can be
difficult to determine however the condition has been divided into two types. Primary OA
is when there is no identifiable initiating event, though risk factors may be present.
Secondary arthritis occurs when there is a likely cause for the onset of OA. The most
common cause of secondary OA is prior injury to the joint. However risk factors such as
age, family history, excess weight, and overuse can contribute to OA development26.

2.3   Non-Operative  Treatment  
There are a number of conservative options to decrease pain and improve function for
patients with mild and moderate OA. These options include: weight reduction, switching
from high impact to low impact exercises (i.e. swimming, biking, elliptical trainer); using
over the counter anti-inflammatory medications, physical therapy, and cortisone
injections28. How long an individual should try conservative treatment is dependent upon
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the recommendations from their physician. Once a patient’s OA becomes severe and
conservative medical therapies are ineffective, surgery can be considered.

2.4   Total  Knee  Arthroplasty  
The TKA has been established as a successful procedure for treating patients with
advanced OA and functions to establish a functional less painful knee with improved
longevity28,29,30. This procedure replaces the surfaces of the damaged knee joint bones
through four basic steps19,28. First, the damaged cartilage surfaces and a small amount of
underlying bone at the end of the femur and tibia are removed in order to prepare for the
installation of components. These implants can be press-fit or cemented into the ends of
the femur and tibia to recreate the surface of the knee joint22,28. The undersurface of the
patella can be cut and resurfaced with an implant depending upon the patient and surgeon
preference. Patellar resurfacing can be performed when patients have a loss of cartilage,
exposed bone, gross surface irregularities, and or anterior knee pain. Finally, a plastic
spacer is secured to the tibial component, with the goal of creating a smooth gliding
femoro-tibial surface19.

2.4.1  Epidemiology    
Total knee arthroplasty (TKA) is the most common elective orthopaedic procedure. It is
performed for severe end-stage osteoarthritis and is associated with significant
improvement in pain, function, and daily activities in patients29. This procedure is
reserved for patients with intractable pain and functional limitations whom have failed
conservative treatment and are not candidates for other procedures such as arthroscopy30.
In 2004 Kurtz et al. developed a predictive model and concluded that because of an aging
population, the number of knee replacement surgeries have drastically risen over the
years and are projected to increase 6-fold from 2005 to 2030 in the United States2.
Furthermore, according to the 2014 Annual Report by the Canadian Joint Replacement
Registry (CJRR) between 2012-2013, approximately 57, 718 knee replacements were
performed in Canada, which is a 21.5% increase from 2008-2009. More specifically there
was a 5% increase in knee replacements from 2011 to 201331. As Ethgen et al. concluded,
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patients with end-stage joint deterioration because of osteoarthritis or rheumatoid arthritis
constitute the largest group of patients who require total knee replacements30.
The demand for lower-limb arthroplasty is expected to increase, as indications for
replacement surgeries extend as a consequence of advancements in prosthetic materials
and expected clinical benefits. The etiology of knee pain that requires treatment with a
TKA is often attributed to osteoarthritis, inflammatory arthritis, and post-traumatic
arthritis28.

2.4.2  Postoperative  Pain    
Since the TKA procedure is invasive, it is often associated with intense postoperative
pain and therefore a comprehensive multimodal analgesic regimen4,11,32,33. Pain
management after a TKA is of great importance because of the high incidence for severe
acute postoperative pain which can interfere with patients’ ability to sleep, walk, and
participate in rehabilitation activities required for hospital discharge3,34. Results from
studies conducted by Chavis and Hawker et al. indicate a fear of poorly controlled pain or
unrelieved pain during hospitalization may result in failure to achieve functional
outcomes. In turn, this may contribute to increased risk for postoperative complications
such as pneumonia, deep vein thrombosis, or pulmonary embolus35,36. Therefore adequate
postoperative pain control is crucial in the immediate and early postoperative period
when pain levels are typically the highest. Earlier discharge, which primarily involves
early rehabilitation, is only possible if pain control is effective and muscle function is
conserved37.

2.5     Analgesic  Drugs    
Analgesics are any member of a drug class used to achieve a relief from pain. Since a
substantial number of patients experience severe pain after TKA, healthcare professionals
prescribe multiple drugs that work via different mechanisms to promote healing and
recovery, faster patient mobilization, shortened hospital stays, and reduced healthcare
costs 38. Major targets for analgesia following TKA are the opioid receptors, nociceptors,
and local inflammatory mediators39.
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2.5.1  Opioid  and  Nociceptors    
Immediately following surgical trauma, peripheral receptors are among the first
expressed, subsequently relaying signals to central receptors40. When peripheral tissue is
damaged, sensory neurons transduce noxious mechanical stimuli into action potentials.
The cell bodies of these neurons are found in the dorsal root ganglia (DRG) and give rise
to A-delta and C nerve fibers18. After synaptic transmission and modulation within the
afferent neurons and spinal cord, nociceptive signals reach the brain where they are
registered as pain. Opioids such as morphine and its derivatives; codeine, oxycodone, and
hydrocodone can produce analgesia by activating opioid receptors on peripheral sensory
neurons. Specifically morphine acts on three peripheral nerve opioid receptors (mu, delta,
kappa) to exert an analgesic effect at the wound site18,40. As indicated by Stein and Lang,
opioids are still the most powerful drugs for severe pain. However, their use is hampered
by side effects such as respiratory depression, nausea, constipation, addiction and
tolerance 40–43,44. As opioids bind to opioid receptors they cause a decrease in the
excitability of the nociceptive neurons producing analgesia. Inhibition of nociceptors is
increased by the use of local anesthetics such as ropivacaine15.

2.5.1.1   Ropivacaine    
Ropivacaine is a local anesthetic drug belonging to the amino-amide group developed for
the purpose of reducing potential toxicity and improving relative sensory and motor block
performance 45. This drug is indicated for local anaesthesia often used in TKA operations
such as local infiltration, peripheral nerve blocks, epidurals, and intrathecal anesthesia.
Ropivacaine is related structurally to bupivacaine, with similar pharmacokinetic
disposition but is less lipid soluble. Ropivacaine use has been popularized since
bupivacaine was correlated with higher CNS and cardiac toxicity46.
Ropivacaine’s mechanism of action is by reversible inhibition of sodium ion influx
causing impulse blockage in nerve fibres. It has selective action on the pain-transmitting
A delta and C fibres over the A beta fibres that are also involved in motor function45. This
selective action is because of its less lipophilic nature than bupivacaine and its
stereoselective properties. Ropivacaine has been shown to provide equal analgesia, allow
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for greater mobility, and reduce opioid consumption in patients following TKA in
comparison to opioid based analgesia47. Ropivacaine can also be administered as a
cocktail containing epinephrine and Ketorolac47. Epinephrine functions to cause localized
vasoconstriction to maintain optimal concentration of ropivacaine at the wound site48.

2.5.2   Ketorolac    
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID). It functions by inhibiting
the production of prostaglandin inflammatory mediators by the eicosanoid pathway,
exerting anti-inflammatory, antipyretic and analgesic effects39. This serves to blunt the
initial pain response. Andersen et al. found that local infiltration containing ketorolac in
combination with ropivacaine and epinephrine resulted in patients consuming less
postoperative morphine for pain in comparison to patients receiving no ketorolac in their
analgesic cocktaila49.

2.6     Analgesic  Techniques  
Adequate pain relief is extremely important in postoperative knee rehabilitation. Many
modes of perioperative analgesia have been reported for patients undergoing TKA.
Patient-controlled analgesia (PCA), continuous epidural analgesia (CEA), peripheral
nerve blocks (PNB), and periarticular infiltration (PAI) are traditional and current pain
management regimens.

2.6.1   Patient-Controlled  Analgesia  
Patient-controlled analgesia is a method that allows patients to administer their own pain
relief through the use of a computerized intravenous infusion pump. Healthcare providers
ensure the pump is programmed specifically for the patient’s pain relief and to prevent
drug overdose. Traditionally, postoperative protocols for TKA were based on a general
anesthetic and opioid intravenous PCA39. Although opioids provide effective analgesia,
they are associated with side effects such as nausea, pruritus, vomiting, dizziness, urinary
retention, sedation, and constipation4–6.
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2.6.2   Continuous  Epidural  Analgesia  
Epidural analgesia involves the administration of drugs through a catheter placed in the
epidural space. The epidural space is the outermost part of the spinal canal, specifically
lying just outside the dura mater18. Within this epidural space, the spinal nerve roots and
small arteries are found. Epidural analgesia involving the combination of a local
anesthetic agent and an opioid has traditionally played a major role in orthopaedic
anaesthesia since its analgesic efficacy is very high33. Studies have indicated that the
benefit of epidural analgesia must be weighed against the risks of its adverse outcomes
such as nausea, pruritus, hypotension, urinary retention, poor muscle control, and delayed
mobilization7.

2.6.3   Lumbar  Plexus  Blocks  
The inhibition of afferent pain fibers is the primary goal of peripheral nerve blocks. The
optimal nerve block, combination of blocks and/or combination of catheter and singleinjection techniques is still a matter of debate33. Winnie et al. introduced an approach to
blocking the lumbar plexus in the early 1970s8,50. The three nerves to the lower limb
arising from the lumbar plexus: the obturator nerve, lateral femoral cutaneous nerve, and
femoral nerve can be blocked by single injection. Also called the ‘3 in 1 block’, the
placement of an indwelling catheter can allow continuous block of the lumbar plexus44.
Winnie et al. indicated that the fascial envelope is identified by the production of a
paresthesia of the femoral nerve. If a sufficient volume of anesthetic solution is injected
to reach the lumbar plexus, a blockade of these nerves results50. Winnie described an
anterior inguinal paravascular approach. In this technique a needle is inserted into the
sheath that surrounds the femoral nerve. The injection is made just below the inguinal
ligament, with the solution being forced cephalad to block the nerves at the level where
they lie closer together in the lumbar plexus. A more common approach is the posterior
lumbar paravertebral approach. The patient is placed on their side and a needle is inserted
into the interfascial space between the quadratus lumborum and psoas major muscles.
This allows the anesthesia to be placed where the roots form the plexus. The main risk of
the advanced lumbar plexus block is the close proximity of the epidural space and retro
peritoneum of the kidney. Mislead catheters, kidney injuries, and local anesthetic
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toxicity have been reported8,54. However, studies have shown that continuous lumbar
plexus blocks (CLPB) have provided adequate analagesia for TKA patients51.
A prospective cohort study conducted by Luber et al.52 enrolled 87 patients with similar
characteristics (age, sex, height, and weight) to receive a combined lumbar plexus and
sciatic nerve block. Their results indicated that 78% of their patients had successful pain
relief using the block alone for an average of 13 hours post operation (range, 4.25-22) 52.
Of the 87 patients, 86 completed a satisfaction survey that contained questions never used
in literature previously. They found that the overall satisfaction rate was 92%, and 95%
agreed to consider lumbar plexus blocks if future surgery was necessary. No control
groups were used in this study.
In 1991 Serpell et al.44 published a randomized clinic trial comparing the analgesic
efficacy of CLPB to a control group for the first 48 hours following TKA. A total of 30
patients were randomly assigned to receive the lumbar plexus block (n=13), or no block
(n=16). The control group did not have a placebo injection at the femoral site. Both
groups were attached to an on-demand analgesic computer (ODAC) set to deliver
morphine upon return to the ward following surgery. The ODAC delivered morphine in 2
mg intravenous boluses to a maximum of 12 mg/hour with a lockout interval of nine
minutes. If further pain control was required, intramascular morphine 10 mg or
paracetamol 1g orally was administered. Outcome measures included pain numerical
rating scales (NRS), morphine consumption, and any adverse effects in the 48-hour
postoperative period. Patients in the lumbar plexus group required a third less morphine
than the control group in the total 40 hour postoperative period (mean(SEM), 60mg(8.7)
vs 91mg(9.8) p<0.05). There were no significant differences in pain scores between the
two groups at 24 and 48 hours and the incidence of nausea and vomiting was not
significantly different between groups. Though this randomized control trial had a
smaller sample size and functional outcomes were not assessed, Serpell et al. concluded
that lumbar plexus blocks offer similar analgesia to continuous morphine, but with
significantly reduced opioid requirements.
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Watson et al.53 assessed functional outcomes in their randomized clinical trial comparing
CLPBs to single injection lumbar plexus blocks (SLPB). They wanted to determine
whether a block infusion is required or whether single-injection nerve blocks alone would
be as a effective. A total of 32 patients were randomly allocated to the continuous block
group (n=16), or the single block group (n=16). Both groups received PCA morphine,
using a 1 mg bolus and a 5-minute lockout period with no background infusion.
Outcomes measured were pain, morphine consumption, motor power, ambulation, and
nausea. Results indicate that total morphine consumption over the 48-hour postoperative
period was significantly reduced by 41% in the CLPB group compared to the SLPB
group (19mg vs 32mg, p <0.05). Days to first mobilization after surgery were
significantly reduced in the CLPB group: 5 patients in this group mobilized in the first
operative day and the remaining 11 on the second day. In the SLPB group no patients
mobilized on the first day, 10 on the second day, and the remaining 6 on the third day
(p<0.01). No significant differences in pain, nausea, motor block, or time to meet
discharge criteria were found between groups.
. Kaloul et al.55 conducted a randomized trial comparing CLPB to continuous femoral
nerve blocks (CFNB) in 60 patients undergoing primary TKA. Their aim was to evaluate
the efficacy of CLPB and CFNBs for postoperative analgesia following TKA. Patients
were randomly allocated to receive PCA with morphine (n=20), PCA plus CLPB (n=20),
or PCA plus CFNB (n=20). Both continuous blocks were set to deliver an infusion of
0.2% ropivacaine at 12 mL/hour for 48 hours following surgery. All patients received
intravenous PCA with one milligram of morphine infused over two minutes with a fiveminute lockout period. Outcomes measured were morphine consumption, pain using a
visual analogue scale, motor blockade (weakness in knee flexion against resistance), and
satisfaction. CFNB and CLPB reduced morphine consumption during the 48-hour study
period by 48% (p=0.0002) and 50% (p<0.0001) respectively compared to PCA. There
was no statistical or clinical difference in morphine consumption between the CFNB and
CLPB groups. Pain scores at rest were significantly reduced in the CLPB and CFNB
groups compared to patients who received PCA (p<0.0001). Pain scores during
physiotherapy did not differ between the three study groups. Patient satisfaction with the
overall pain management was high with no significant differences between the groups
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(PCA 86.5±10.3; CFNB 94.8±8.2; CLPB 93.0±7.8). However, motor blockade was
achieved more frequently in the CLPB group than in the CFNB group (p<0.0001). Motor
blockades can be linked to patient falls inhibiting adequate postoperative rehabilitation.
Lumbar plexus blocks can be used as regional anesthesia for patients undergoing TKA;
however because of the potential for complications and advanced skills to perform the
block, it is currently not widely used8.

2.6.4   Femoral  Nerve  Blocks    
The femoral nerve block (FNB) was first described in the 1920’s by Labat56. In contrast
to the lumbar plexus block, femoral blocks have a well-defined insertion site that is based
on three land marks; the inguinal ligament, inguinal crease, and femoral artery8. FNBs
are common methods for postoperative pain control after TKA that are easy to administer
and are associated with low risks of complications57. The femoral nerve alone only
provides sensation to the anteromedial aspect of the knee. Therefore, the femoral nerve
block can be performed in combination with a sciatic nerve block, which innervates the
posterior aspect of the knee. Studies indicate that FNB’s offer improved or equivalent
patient pain scores, length of stay, and morphine consumption compared to more
traditional techniques57–59.
In 2010, Paul et al.57 performed a meta-analysis of randomized trials that compared PCA
opioids alone or epidural analgesia versus patients receiving FNB (single shot or
continuous) for up to 72 hours following TKA. Studies included addressed at least opioid
consumption and pain scores. Additional outcomes such as opioid side effects, knee
range of motion, length of stay, early ambulation, and patient satisfaction were extracted
if available. Following article screening, 23 RCT’s were extracted and assessed for
quality. Of the selected studies included, 14 compared FNB with PCA, four compared
FNB with epidural, three compared different types of FNB (single shot FNB, continuous
FNB, sciatic combined with continuous or single shot FNB), and two compared FNB
with both epidural and PCA. Overall 665 patients received FNB, 161 received epidural,
and 190 received PCA. Regarding opioid consumption, patients receiving single shot
FNB, sciatic combined with single shot FNB, and continuous FNB had significantly less
morphine consumption at 24 hours (compared with PCA alone) with differences of -20, -
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31, and, -15 mg respectively. There were no significant differences in pain, motor block,
patient satisfaction, and length of stay between comparison groups up to 48 hours
following TKA. A small number of studies in this meta-analysis reported side effects;
therefore all types of FNBs were grouped together in comparison with PCA. Results
showed that FNB groups had significantly less nausea (0.31 odds) compared with PCA
patients.
Min Lee et al.59 conducted a retrospective study comparing PCA versus continuous FNB
in 1582 post-TKA patients. Intravenous PCA was not used in patients who received FNB.
Outcomes included the incidence of severe pain (visual analogue scale (VAS)>6), and
incidence of adverse reactions. One thousand and three patients received PCA and 579
patients received FNB. The incidence of severe pain (VAS>6) from postoperative day
(POD) 1-3 was higher in the PCA patients (69.1%) compared to the FNB group (32.3%)
(p=0.003). There was one incident of hypotension and one incident of respiratory
depression in the PCA group but no documented adverse events in the FNB group.
Evidence published by Chan et al.60 in 2013 suggests that whether the FNB was
performed as a single injection or a continuous FNB block, pain scores and functional
outcomes were superior to PCA in the postoperative period. However, whether the FNB
should be performed as a single shot block or as a continuous block was up for debate. In
their randomized trial 200 TKA patients were allocated to one of three regimens; single
FNB (n=69), continuous FNB (n=65), or intravenous PCA (n=66). All patients had
similar characteristics. In the FNBs the local anesthetic used was 20 mL of 0.25%
bupivacaine with 1:400,000 adrenaline (2.5 mcg/mL). For the continuous FNB the
catheter was connected to a pump to deliver bupivacaine 0.125% 4 mL/h, which is the
standard at this study’s center. PCA was initiated immediately after surgery via a pump
set to deliver bolus doses of morphine 1mg with 5-minute lockout (maximum 10 mg/h).
The primary outcome was significant pain on movement (VAS>4) at postoperative 24
hours. Secondary outcomes were knee pain at rest or movement, cumulative opioid
consumption, side effects, and days to achieve 90-degree active knee flexion. The
proportion of patients with significant knee pain on movement at 24h after TKA was
significantly lower in the single injection (OR 0.36; 95% CI 0.15 to 0.86; p= 0.022) and
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continuous FNB groups (OR 0.25; 95% CI 0.11 to 0.60; p=0.002), compared to patients
receiving PCA (OR 1). Knee pain at rest was significantly lower in the continuous FNB
group at 6 hours (mean difference -1.19, 95% CI -2.18 to -0.21, p=0.018) and at 24h
(mean difference -0.67, 95% CI -1.18 to -0.17, p=0.010) compared to the PCA group.
Knee pain during movement was significantly lower in both the continuous (mean
difference -1.15, 95% CI -1.72 to -0.58, p<0.0001) and single-injection (mean difference
-0.58, 95% CI -1.14 to -0.01, p=0.045) FNB groups at 24h compared to the PCA group.
The continuous FNB group reported significantly less pain on movement at 24h (mean
difference -0.57; 95% CI -1.14 to -0.01; p=0.045), when compared to the single-injection
FNB group. Prior to 24 hours there was no significant difference in pain between the
single and continuous techniques. This result is most likely because of the duration of
analgesia of the single-injection FNB block not lasting 24 hours. Opioid consumption for
both FNB groups was significantly lower compared to the PCA group. The opioid
consumption for the continuous FNB group was also significantly less compared to the
single-injection FNB (mean difference at Day 1 morning: -18.5; 95% CI -25.6 to -11.4;
p<0.001; and mean difference at Day 2 morning: -24.4; 95% CI -34.9 to -13.9; p<0.001).
The single-injection (SI) and continuous (C) FNB groups reached ROM of 90 degrees
earlier than the PCA group (SI: 2.3 days (1.4) p= 0.014, C: 2.4 days (1.4) p=0.024, PCA:
3 days (1.6)). Recorded side effects were lower in the FNB groups compared to PCA. No
adverse events such as falls were recorded. Length of stay was comparable regardless of
allocation. Chan et al.60concluded that both single-injection and continuous FNBs were
generally more effective than PCA, with continuous FNBs providing additional clinical
benefits compared to single-injection FNBs. However, placement and management of
catheters can be time consuming and require additional resources in terms of skill and
cost which should be considered5. They recognized that their study was not designed to
have sufficient statistical power to detect all small differences in treatment benefits
between the two FNB groups. Furthermore, patients and clinicians were not blinded to
treatment allocation and intraoperative parameters (spinal/general, PCA opioids) were not
standardized since they followed their center’s protocols and clinician’s preferences.
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One major reported drawback with FNBs is quadriceps weakness leading to inpatient
falls in fast track arthroplasty regimens10,61. A reduction in quadriceps strength of up to
80% can be observed8,62. This occurs when efferent motor nerves are interrupted
predisposing a patient to falls during the early postoperative period when rehabilitation
practices are important1,63. Pelt et al., evaluated the rate of falls in 707 primary TKA’s
performed at their center and found a 2.7% incidence rate64. They reported this incidence
rate as unacceptably high. Ilfeld et al. also reported seven falls in 171 TKA patients
receiving a femoral nerve block9. Each fall occurred in the experimental femoral nerve
block group in this clinical trial. Catheter dislodgement and nerve injury can also occur
during the patients’ recovery. Memtsoudis et al. did not find an increase in the odds for
inpatient falls when peripheral nerve blocks were used in a population based analysis of
190,000 patients2. Therefore a careful choice of block technique and anesthetic volume is
necessary after carefully weighing the benefits and possible limitations of each technique.

2.6.5   Adductor  Canal  Blocks  
The adductor canal block (ACB) or saphenous block is a modification of the FNB
and has been gaining popularity in the anesthesia community over the last few years33.
Initially described by Lund et al., the ACB block involves injection of local anesthetic
into the adductor canal deep to the sartorius muscle resulting in an almost purely sensory
blockade65. This block technique is a technically easy and reliable method for blocking
the saphenous nerve66.
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Figure 3: Cross-sectional MRI scan of the adductor canal.
The scan shows the position of the saphenous nerve lateral to the artery and anterior to the vein.
Arrow points to the saphenous nerve. A, femoral artery; V, femoral vein; LA, local analgesic;
SM, sartorius muscle; RFM, rectus femoris muscle; VMM, vastus medialis muscle; ALM,
adductor longus muscle; AMM, adductor magnus muscle; GM, gracilis muscle.
Reproduced with permission from Lund et al. Continuous adductor-canal-blockade for adjuvant
post-operative analgesia after major knee surgery: Preliminary results. Acta Anaesthesiol Scand.
2011;55(3):14-1959.

2.6.5.1   Adductor  Canal  Block  vs  Placebo  
Jenstrup et al.62 conducted the first blinded randomized clinical trial comparing the
analgesic efficacy of a continuous adductor canal block to a placebo. Overall 75 patients
were randomly allocated to receive an ACB with 0.75% ropivacaine (n=37) or a placebo
infusion with isotonic saline (n=38). A continuous infusion of ropivacaine or saline was
administered postoperatively as per allocation. All patients received intravenous PCA.
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Postoperative outcomes assessed were cumulative morphine consumption, VAS pain
scores, knee ambulation assessed by timed up and go (TUG) test, and nausea. Total
morphine consumption from 0 to 24 hours postoperatively was significantly reduced in
the ropivacaine group compared with the saline group (40±21mg vs 56±26mg;
respectively, 95% CI -27 to -5mg; p=0.006). Pain scores during activity from 2 to 24
hours was significantly lower in ropivacaine group (p=0.01). This same result did not
reach significance at rest. They concluded that administration of high-volume local
anesthetic into the adductor canal is a useful option for postoperative analgesia after
TKA. Patients in the ropivacaine group performed the TUG test at 24 hours
postoperatively faster than patients in the placebo group (36 ±17s vs 50 ±29s,
respectively p=0.03). There was no significant difference in this functional test at 26
hours between groups. Regarding side effects, no significant differences in nausea or
vomiting were found.
By targeting the adductor canal, the largest sensory branch of the femoral nerve; the
saphenous nerve, the medial femoral cutaneous nerve, and the articular branches of the
obturator nerve are blocked. The nerve to the vastus medialis, a motor nerve is also
blocked11. As a result, the ACB leaves three out of the four components of the
quadriceps muscle unblocked. Numerous studies have shown less reduction of quadriceps
muscle strength, less reported falls, and improved functional outcomes in comparison to
patients receiving the FNB11–14,62.
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Figure 4: Ultrasonography image of the adductor canal.
Midthigh level at a distance approximately halfway between the iliac spine and the patella. SM,
sartorius muscle; A, femoral artery; V, femoral vein and branch. Arrow points to the saphenous
nerve.
Reproduced with permission from Lund et al. Continuous adductor-canal-blockade for adjuvant
post-operative analgesia after major knee surgery: Preliminary results. Acta Anaesthesiol Scand.
2011;55(3):14-1959.

2.6.5.2   Adductor  Canal  Block  vs  Femoral  Nerve  Block  
In 2015, Grevstad et al.11 performed a randomized clinical trial hypothesizing that pain
relief provided by the single injection ACB could improve functional quadriceps muscle
strength in comparison to single injection FNB after TKA. In this single-center,
randomized and blinded trial, 50 patients were randomized to receive either; 3x10 mL
containers with 0.2% ropivacaine for the ACB and 3x10 mL containers with isotonic
saline for the FNB (ACB group) or 3x10 mL containers with isotonic saline for the ACB
and 3x10 mL containers with 0.2% ropivacaine for the FNB (FNB group). Patients with
severe pain (VAS >60/100) were approached and assessed for study inclusion on post
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surgical day one or two. All patients received a standardized multimodal analgesic
regimen including local infiltration and slow-release opioids. The primary outcome was
the difference of maximum voluntary isometric contraction (MVIC) of the quadriceps
femoris muscle between groups at two hours after block performance. This result was
expressed as a percentage of the baseline MVIC taken before block performance. TUG
tests, ability to ambulate, pain scores at rest, activity, and during TUG test were assessed
as secondary outcomes at two hours after block performance. Muscle strength was
assessed with a handheld dynamometer. During the performance of TUG tests, all
patients used a 4-wheel walker. Quadriceps MVIC was significantly higher in the ACB
group, with a median change from baseline of 193% (95% CI, 143%-288%) vs 16%
(95% CI, 3-33%) in the FNB group. At two hours after block performance all patients in
the ACB group were able to perform the TUG test in comparison to 28%, (7/25) of the
FNB group patients who could not. Of this seven, six were could not stand up because of
muscle weakness and one because of dizziness. Patients in the ACB group performed the
TUG test significantly faster (32 seconds, 95% CI 27-37s) compared to the FNB group
(52 seconds, 95% CI, 41-62s), with a mean difference of 20 seconds (95% CI, 9-30s,
p=0.001). No significant differences for pain at activity or rest were found between the
groups from zero to two hours. Though this study demonstrated that ACB increased
quadriceps muscle strength and functional outcomes compared to FNB, this study only
looked at the immediate effects after block performance (2 hours) and did not investigate
longer term (24-48 hours) functional or pain outcomes, which may be more clinically
relevant.
Patterson et al.12 conducted a retrospective chart review of TKA procedures performed at
their center in order to determine if single injection ACB provided adequate analgesia
and improved physical therapy performance in comparison in patients who received
FNB. Patients in the ACB group (n=39) received single shot ACB with 15 to 30 cc of
0.5% bupivacaine. Patients in the FNB group (n=41) received a catheter bolused with 30
to 40 cc of 0.25% ropivacaine followed by a continuous postoperative infusion of 0.2%
ropivacaine at 6 to 8 cc/h. In addition to the block, all patients received hydromorphone
PCA as well as multimodal analgesia. Cumulative opioid consumption and pain scores
(VAS) were assessed at discharge from the postanesthesia care unit (PACU), 8 ± 3, 16 ±
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3, and 24 ± 3 hours. Functional outcomes measured were gait distance during
physiotherapy at postoperative day one. Results indicated that there were no significant
differences between groups in opioid consumption or pain scores at any of the time points
assessed. However, the median gait distance was significantly greater in the ACB group
compared to the FNB group (median, 25ft (4-60) vs. 6ft (4-60); p=.0009). Therefore,
Patterson et al. concluded that single-shot ACB provides equivalent analgesia to a
continuous FNB within the first 24 hours after TKA and improves gait distance during
physiotherapy. Since every participant in this study received local infiltration it is not
clear if the analgesic benefits were a result of the ACB or the local infiltration.
Furthermore, all patients received postoperative hydromorphone analgesia, which could
have further lowered pain scores. Adverse events and side effects were not reported and
since data was collected retrospectively and without randomization, the study could have
been biased.
Kim et al. 13 conducted a blinded randomized trial comparing ACB to FNB in patients
undergoing TKA. They hypothesized that ACB would cause less quadriceps motor
weakness than FNB and provide non-inferior analgesia determined by pain scores and
opioid use. Overall 94 patients were randomly allocated to receive FNB (n=47) or ACB
(n=47). Patients in the ACB group received ultrasound-guided single injection ACB with
15 cc of 0.5% of bupivacaine with 5 ug/mL epinephrine. Study patients in the FNB group
received ultrasound-guided single injection FNB with 30 cc of 0.25% of bupivacaine
with 5 ug/mL epinephrine. All patients received a standardized epidural PCA regimen,
which was discontinued on postoperative day two. The primary outcomes measured were
quadriceps muscle strength (via dynamometer) and pain scores (NRS) at baseline, six to
8, 24, and 48 hours postanesthesia. Opioid consumption was measured from surgery to
postoperative day two. Secondary outcomes included side effects, length of stay, and
patient satisfaction. A joint hypothesis test was performed on all three primary outcomes
previously mentioned at 6 and 8 hours postanesthesia administration. Results indicated
that ACB was found to be non-inferior to FNB in motor score readings (mean difference
5.2kgf; 95% confidence limit (3.1, 7.2); delta -3, p<0.0001). For pain scores at rest and
opioid consumption non-inferiority was also found. Next, a superiority test was
conducted and found only the muscle strength readings for the ACB to be superior to the
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FNB readings (difference ACB-FNB kgf (98.3% CI), 5.2 (2.7-7.7); p<0.0001). Muscle
strength readings were further compared and interestingly at 24 and 48 hours, the ACB
and FNB groups were not statistically different (p<0.9999). For pain and opioid
consumption at 24 and 48 hours, the ACB group was found to be no worse than the FNB
group. No significant differences were found in secondary outcomes such as nausea,
length of stay, and patient satisfaction. However, this study was underpowered to detect
differences in nausea. In this study muscle strength was found to be reduced compared to
baseline. They found that this could be because of nerve blockage to the vastus medialis,
pain limiting painful extension, and the effects of surgery and tourniquet use on
quadriceps strength. Successful pain relief in this study could have also been attributed to
the postoperative use of an epidural PCA.
Though numerous studies suggest that ACBs spare motor function to a higher degree
than FNBs, practitioners still question the analgesic equivalence of these two approaches.
The issue in this comparison is that pain perception is highly dependent on the individual
causing inter-patient variability67.
Memtsoudis et al.1 conducted a novel clinical trial to address this issue by randomizing
60 patients undergoing bilateral TKA to receive ultrasound-guided FNB on one leg and
ACB on the other. The primary outcome assessed was postoperative pain in either
extremity at six to eight, 24, and 48 hours postoperatively. Secondary outcomes included
motor strength and patient satisfaction. Patients, surgeons, physical therapists, and the
research assistant performing follow-ups were blinded to the allocations. ACBs were
performed by injecting 15 mL of 0.25% bupivacaine and FNBs with 30 mL of 0.25%
bupivacaine. All patients received an epidural catheter to assist in postoperative pain
control. Group one (n=30) had a left leg saphenous block and a right leg femoral block.
Group two (n=29) had a right leg saphenous block and a left leg femoral block. Average
pain levels at rest and with exercise were lowest at six to eight hours postoperatively and
increased thereafter (p<0.001), but no significant differences were seen between
extremities at any time point (p=0.4154). In a direct extremity comparison, 25.4% (15/60)
of patients reported that the leg which received FNB was more painful, 50.9% (30/60)
expressed that the side receiving the ACB had more pain and 23.7% (14/40) reported
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both being equally as painful (p=0.0168). No significant differences in muscle strength
were found between extremities at any time point or as an average in the postoperative
period (p=0.7548). Patient satisfaction was also similar for both nerve blocks. Since all
patients received epidural analgesia this can interfere with the independent impact of the
nerve block outcome but each block should have been equally affected. Furthermore,
bilateral TKAs could also be associated with more profound physiological changes and
should be interpreted differently that unilateral TKAs1. They concluded that the use of
ACBs vs. FNBs in knee arthroplasty patients yielded clinically similar results in pain
scores, motor strength, and patient satisfaction.

2.6.5.3  

Continuous  Adductor  Canal  Block  vs.  Continuous  Femoral  
Nerve  Block  

A randomized trial conducted by Shah et al.14 assessed 98 patients comparing continuous
ACB (n=48) to continuous FNB (n=50) after total knee arthroplasty. They aimed to
investigate the efficacy of these two approaches with respect to: ambulation ability, pain
control, opioid consumption, treatment related side effects, and length of stay. In both
groups, the patients were given an initial dose of 30 mL of 0.75% ropivacaine, followed
by repeated boluses of 0.25% ropivacaine every four hours until the second day after
surgery. Patients also received intravenous PCA. Patients were assessed for pain at four,
eight, 12, and 24 hours postoperatively using a VAS scale with 0= no pain and 100=
worst imaginable pain. TUG tests and ten meter walk tests were performed at 24 hours
post block performance to assess ambulation ability. Tug test results showed significantly
better results in the ACB group as compared to the FNB group (95% CI -147 to -108.5;
p<0.001). In the 10-m walk test assessments, the ACB group again performed
significantly better than the FNB group (95% CI -236.33 to -177.06; p<0.0001). Patients
in the ACB had a significantly shorter length of stay then the FNB group (3.08 vs 3.92; p
value <0.001). Postoperative pain scores were lower in the ACB group than in the CFNB
group at 4, 8, 12, and 24 hours postoperatively but without any significant intergroup
differences (p value > 0.001). Finally, one patient in each of both groups had nausea and
a single episode vomiting. In the study population, 71 out of 98 were females and both
groups received intravenous PCA combined with oral analgesics which could influence
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pain perception14. Blocks were also administered to patients immediate postoperatively.
Shah et al. concluded that though continuous ACBs showed no significant difference
from continuous FNBs in analgesic effect, ACB provided better ambulation ability and
faster recovery post TKA.
Overall, in the early postoperative period (24 hours post-op) ACBs seem to offer an
improved retention in muscle quadriceps muscle strength in comparison to FNBs leading
to an improved performance in rehabilitation activities. Though ACBs have this
advantage, studies indicate FNBs and ACBs are equivalent in outcomes such as pain,
opioid consumption, and nausea in the early postoperative period11–14,20,62. Therefore
ACBs can be a reasonable alternative and provide adequate analgesia and significant
spared motor strength in comparison with the FNB.

2.6.6   Periarticular  Injections    
Periarticular injections (PAI) or local infiltration is an analgesic technique which involves
the injection of analgesic drugs into injured tissue such as the synovium, joint capsule,
and subcutaneous tissues during TKA68,69. It was designed to specifically avoid sedation,
facilitate rapid physiological recovery, and to enable early mobilization and discharge by
not compromising muscle tone5,70,71. These injections often use medications to target
opioid receptors, nociceptors, and local inflammatory mediators39. First described by
Kerr and Kohan, local infiltrations contain a mixture of ropivacaine (2mg/mL), ketorolac
(30mg), and adrenaline (10ug/mL) in volumes of 150-170mL for TKA5,71. Injections are
usually administered in three stages during a TKA. The first injection is done after bone
surfaces have been prepared before components are inserted to ensure access to the
posterior joint capsule. Approximately 30-35 mL, is injected to the tissues around the
posterior joint capsule, using a systematic sequence from one side to the other to ensure
uniform delivery71. The second injection (35-50 mL) is done after component insertion
but before wound closure and tourniquet release. This injection is into the deep tissues
around the medial and lateral collateral ligaments and wound edges. The third injection
(25-50 mL) is made into the subcutaneous tissue, carefully avoiding subdermal injection.
Multiple injections are made in a systematic sequence. Each time the needle is inserted
perpendicular to the wound edge to a depth of about 25mm, an injection is done as the
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needle is withdrawn71. An intra-articular catheter for continuous infusions may be
inserted preferably near the posterior aspect of the joint. Lastly, a compression bandage is
applied to reduce degradation and slow the diffusion of local anaesthetic into the
bloodstream42,72.
A meta-analysis conducted by Xu et al. (2014)69 assessed the effectiveness and safety of
single injection PIA in comparison to patients who received a placebo or no intervention
after TKA. Studies included were RCTs that reported one or more of the following
outcome measures: VAS, postoperative morphine consumption, length of stay, early
functional recovery, and side effects. Following study screening and selection, 18 RCTs
were extracted and included in their meta-analysis. Heterogeneity across studies was
tested using the I2 statistic. If a moderate to high degree of heterogeneity existed, they
estimated the influence of each individual study on the summary result. This post-hoc
test consisted of repeating the random-effects meta-analysis after omitting each study one
at a time. A total of 1858 study patients were involved in this analysis. Of the 18 studies
analyzed, 16 reported VAS pain values in study patients. Analysis of these 16 RCTs
indicated that patients receiving single injection PAI had significantly lower pain values
at two, four, six, 12, 24, and 48 hours postoperative compared to control patients
receiving saline injections or nothing (p<0.05).There was some heterogeneity amongst
these sixteen studies and so they omitted one study at a time and calculated the pooled
weight mean differences for the remaining studies. This post hoc analysis showed no
changes in the direction of effect for pain when any one study was excluded.
Only eight RCTs from the extracted studies reported postoperative morphine
consumption. Analysis of these eight RCTs indicated that single-dose PAI was associated
with decreased postoperative morphine consumption (WMD -5.21, 95% CI -9.89 to 0.52; p =0.03; heterogeneity p<0.01, I2= 79.1%).They decided to repeat the randomeffects meta-analysis after omitting one out of the eight studies at a time since there was
significant heterogeneity. When one study was excluded during this post-hoc exploration,
the direction of effect changed indicating no significant difference between groups in
postoperative morphine consumption. This was a separate result and the authors did not
indicate which was correct. The time to short leg raise (4 studies) was significantly
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shorter in the PAI group than the control groups (WMD, -2.75 days; 95% CI, -3.61 to 1.90; p <0.01; heterogeneity p<0.01, I2 = 85.4%). After the same post-hoc single
exclusion of studies because of heterogeniety, there were no changes in these results. No
significant differences were found between PAI and control groups regarding
postoperative nausea and vomiting, pruritus, and DVT. This meta-analysis demonstrated
considerable heterogeneity across the trials, which could have resulted from nonstandardized PAI (medication ingredients, dosages). A major limitation in this metaanalysis was the post-hoc exclusion of studies to explore if there was a change in the
direction of effect. If one study was excluded and the direction of effect changed they
would not report which was the correct result. Furthermore, different patients might have
had varying responses to analgesia because of the type of anesthetic used during surgery
and postoperative multimodal regimens. Overall, this study concluded that that single
injection PAI is significantly better than placebos at relieving pain, and might accelerate
early functional recovery of the knee while not increasing the prevalence of side effects
during postoperative observations.

2.6.6.1   Periarticular  Infiltration  vs.  Placebo  or  Traditional  Analgesia  
Compared to more traditional analgesic methods (PCA, intrathecal narcotics, or
epidurals) in placebo controlled studies, patients receiving single injection or continuous
PAI had equivalent or lower pain scores in the postoperative period39,47,73,74, lower
consumption of morphine4,39,47,73,74, better functional outcomes39,47,75, and less
complications4,43,47. Evidence has lead to peripheral nerve blocks and PAI largely
replacing epidural analgesia for postoperative pain management following TKA76.
In 2014, Niemelainen et al.73 randomized 56 patients undergoing TKA to receive either
single injection PAI or placebo in this study. In the PAI group, a cocktail mixture of
levobupivacaine (150 mg), ketorolac (30 mg), and adrenaline (0.5 mg) for a total volume
of 150 mL was infiltrated. In the placebo group saline was infiltrated for a total volume
of 150 mL. Only an independent nurse who prepared the study solutions was unblinded
to group allocations. In addition, all patients were given PCA with oxycodone to ensure
pain relief. The primary outcome assessed was oxycodone consumption over 48 hours
postoperatively. Secondary outcomes included pain and range of motion (ROM). Overall
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27 patients in the PAI group and 29 patients in the placebo group completed the study.
Results showed that cumulative consumption of oxycodone was smaller in the PAI group
to that in the placebo group at all measured time points up to 48 hours. However, in
comparison of the different time intervals, the PAI group used significantly less
oxycodone than the placebo group during the first six hours (mean: 14 (2-34)mg vs 30 (657)mg ; p<0.001). The rest of the time points did not reach statistical significance. Both
groups achieved a median level of pain (VAS <3) until 48 hours. The difference in mean
ROM at 6 hours between the PAI group and the place group was -26 degrees (95% CI: 39 to -12). Niemelainen et al. showed that a single intraoperative PAI containing
levobupivacaine, ketorolac, and adrenaline reduced the total consumption of oxycodone
during the first 48 hours postoperatively. The beneficial effect of single injection PAI
was most pronounced during the first six hours as seen by the increased ROM and equal
pain scores were recorded between both groups. This study however did not measure
length of stay between groups. Levobupivacaine was also used in the PAI cocktail, which
according to Niemelainen et al. has a longer effect time than ropivacaine. In theory this
should prolong postoperative analgesia.
Lamplot et al.39 performed a randomized controlled trial of patients undergoing a primary
TKA. Patients were either randomized to receive either intraoperative single injection
PAI and inpatient multimodal analgesics (PAI group) or to hydromorphone PCA (PCA
group). During surgery patients in the PAI group received single injection PAI consisting
of 30 cc 0.5% bupivacaine, 10 mg MSO4, and 15mg ketorolac. Postoperative multimodal
pain management was given to these patients. During surgery, patients in the PCA group
received no injections. For postoperative pain management these patients received
hydromorphone PCA. Recorded measures in this study consisted of; VAS pain scores,
narcotic consumption, medication-related adverse effects, length of stay, satisfaction, and
time to physical therapy milestones. Overall, 36 patients of an eligible 55 were
randomized to the two groups; PAI (n=19) and PCA (n=17). Daily narcotic consumption
was significantly lower in the PAI group compared to the PCA group, with 17.0mg±3.85
versus 40.5±12.7 at the end of postoperative day 0, 30.8±5.5 versus 71.8±15.5 during day
1 and 18.4±5.5 versus 38.1±11.5 during day 2, respectively (p<0.007). During the
hospital stay, fewer patients in the PAI group (3/19) experienced narcotic-related adverse
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effects in comparison to the PCA group (16/17), including nausea, vomiting,
constipation, insomnia, pruritus, and mood irritability (p<0.01). The VAS pain scores for
postoperative pain at rest (p<0.0004) and activity (p<0.001) were significantly lower in
the PAI group during each day of hospitalization. The ability to walk assisted >50ft was a
physical therapy milestone recorded in this study. For this milestone 7/17 patients in the
PAI group were able to perform this compared to 0/16 in the PCA group. Furthermore,
on day one after surgery 19/19 patients in the PAI group were able to achieve this
milestone compared to 6/17 in the PCA group. There was a trend toward decreased
length of stay in the PAI group, with a mean of 1.9 days compared to 2.3 days in the PCA
group. Patients in the PCA group also reported significantly higher satisfaction scores
compared to the PCA group during each postoperative day (p<0.05). Lamplot et al. found
the patients receiving intraoperative single injection PAI had significantly improved
patient pain control, medication-related adverse effects, functional outcomes, and patient
satisfaction. Though this study seemed to have a small sample size, it was unanimously
decided at their center that patients in the PAI group were having markedly better
outcomes. Therefore, they stopped short of reaching their goal of enrolling 30 subjects in
each group.

2.6.6.2   Single  vs.  Continuous  Periarticular  Injections  
In subsequent years, different cocktail mixtures of opioids and steroids have been
administered to patients with no agreed upon gold standard mixture4,33. This discrepancy
is because of considerable variability in factors affecting drug therapy outcomes in
available clinical studies. PAIs can either be performed as single or intermittent
injections, continuous infusions with the use of an intra-articular catheter, or a
combination of methods, and with varying compositions of the drug solution77.
Controversy exists over which model of delivery is most effective. Continuous infusions
often involve catheter placement by the surgeon at the end of surgery under aseptic
conditions while requiring the use of bacterial filters and closed infusion systems.
Catheters are difficult to manage with the potential for problems while troubleshooting
them5. However, the placement of a catheter in continuous infusions allows for prolonged
site-specific regional analgesia which may be beneficial16. By contrast, single injection
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PAI is common in clinical practice and reported to be inexpensive and relatively easy to
perform and have fewer side effects69.
Zhang et al.16 conducted a randomized blinded and placebo-controlled trial with the aim
of evaluating whether continuous PAI provided prolonged and superior analgesia and
reduced morphine consumption in comparison to single PAI. A total of 80 study patients
completed the study and were randomly allocated into three groups; continuous PAI
(n=27), single injection PAI (n=27), or a control group (n=26). Patients in the continuous
PAI group received ropivacaine (190mL, containing 2mg/mL) via continuous infusion
(flow rate 4 mL/h for 48 hours) plus 2 mL ketorolac (30mg/mL) at 1.25 mg/h. Patients in
the single injection PAI and control group received a continuous infusion of saline
through the catheter. Study patients in the continuous and single PAI groups at the end of
surgery received periarticular infiltration of a mixture of ropivacaine 150mL (2mg/mL),
ketorolac 1mL (30mg/mL), and adrenaline 0.5mL (1mg/mL). For rescue analgesia, all
patients received intravenous PCA consisting of morphine for the first 48 hours post
surgery. Knee pain was evaluated after surgery at two, four, eight, 12, 16, 20, 24, 30, 36,
and 48 hours and the amount of morphine delivered via the PCA pump was also
recorded. Patient satisfaction and complications during the follow-up period of three
months were recorded. The resulting VAS pain scores at rest and during activity were
significantly higher in the control group than in the continuous PAI group (p<0.05)
through the 48 hour postoperative period. In contrast, no significant differences in the
VAS pain scores at rest between the control group and single injection PAI group at 2048 hours postoperatively were found. VAS pain scores in the continuous PAI group were
significantly lower than the single injection PAI group (p<0.05) from eight to 48 hours
postoperatively at rest and from 16 to 48 hours postoperatively during activity (p<0.05).
Morphine consumption was only significantly higher in the control group compared to
the single injection PAI group during 0-12 hours and 12-24 hours postoperatively
(p<0.05). In comparison to the continuous PAI group morphine consumption was
significantly higher in the control group throughout the entire 48-hour postoperative
period (p<0.05). In addition, morphine consumption from 24-48 hours was significantly
reduced in the continuous PAI group compared to the single injection group (p<0.05).
The incidence of nausea and vomiting was higher in the control group than the two PAI
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groups however this difference was not statistically significant. There were no significant
differences in satisfaction between the two PAI groups, and no complications, infections,
or reparations occurred during the follow-up period. This studies sample size was too
small to evaluate the risks of infection in the different techniques. Zhang et al.16
concluded that continuous PAI is associated with prolonged, superior analgesia and
reduces morphine consumption compared to single injection PAI over the 48-hour
postoperative period. They also recorded a higher incidence of patient satisfaction in the
continuous PAI group but still state that it is important to consider the risk of infection
with different PAI techniques.

2.6.6.3  

Periarticular  Infiltration  vs.  Femoral  Nerve  Blocks  

Recently, Wang et al.78 conducted a systematic review and meta-analysis comparing
PAIs and FNBs for postoperative pain management in TKAs. Randomized control trials
were identified that compared patients receiving PAI or FNB whether they were single or
continuous techniques. Outcome assessed were; pain scores, opioid consumption,
functional outcomes, length of stay, and side effects. Following study exclusions, ten
RCTs were identified with a total of 744 TKAs performed in 728 patients. In this
analysis, four studies used PAI with a catheter and six as a single injection. Six studies
performed a continuous FNB while the other three used a single injection FNB. One
study looked at bilateral TKAs. Results of nine RCTs that were analyzed indicated that
there were no significant differences in VAS pain scores at rest between the PAI and
FNB group at 24 hours postoperative (95% CI -0.62 to 0.37; p=0.62). A subgroup
analysis was performed on the different analgesic techniques (single or continuous). A
meta-analysis of two of their studies showed that single injection FNBs had lower VAS at
rest pain scores at 12 hours than single injection PAI (95% CI 0.18 to 0.79, p=0.002).
However, the results of four combined studies indicated single injection PAI significantly
reduced VAS pain at rest at 24 hours compared to single injection FNBs (95% CI -1.44 to
-0.09; p=0.03). No significant differences were found between the two groups regarding
pain at activity. A total of seven studies in this meta-analysis were analyzed for total
opioid consumption and no significant differences were found between PAI and FNB at
24 hours (p=0.64) or at 48 hours (p=0.99) postoperatively. Three studies indicated that
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the number of patients able to do active straight leg raises at 24 hours following TKA was
significantly larger in the PAI group (OR=11.09; 95% CI=6.24 to 19.69; p<0.001). Metaanalysis results from six studies of 390 TKAs showed that patients receiving PAI had
significantly shorter length of hospital stay then FNB patients (95% CI -0.52 to -0.02;
p=0.04). No significant differences were found in complications such as nausea,
vomiting, and wound complications between the two groups. It appears that continuous
PAIs are an efficient and safe alterative to continuous FNBs for postoperative pain
management following a TKA. However, in this meta-analysis there was a lack of
uniform technique of PAI and FNB. Furthermore, single injection FNBs may provide
better pain relief in the early postoperative period compared to single injection PAIs.

2.6.6.4  

Single  Injection  Periarticular  Injections  vs.  Single  Injection  
Femoral  Nerve  Blocks  

In a large randomized blinded trial by Uesugi et al.15, 210 patients undergoing a TKA
were randomized to receive either single injection PAI (PAI group) or a single injection
FNB with a combined sciatic block (FNB group). Patients in the PAI group (n=100)
received intraoperative periarticular injections containing 20mL of 0.75% ropivacaine
and 0.3mg of adrenaline. Patients in the FNB group (n=100) received a total 30mL of
0.75% ropivacaine for peripheral nerve blockade as per the standard of their center. If
patients were in postoperative pain they were given diclofenac sodium suppositories
(25mg) as required. Primary outcomes measured were postoperative pain, total rescue
medication consumption, motor paralysis, satisfaction, and complications. Results
indicated that from three to six hours following surgery pain scores were significantly
lower in the FNB group (p<0.01, p<0.01). No significant differences were found between
the groups from 12 to 18 hours postoperatively. Pain scores were significantly lower in
the PAI group at 24 hours (p<0.01) and 30 hours (p<0.01). From 30 hours on there were
no significant differences between the two patient groups. During the zero to 12 hour
postoperative period, patients in the FNB group used significantly fewer rescue pain
medications than patients in the PAI group (6h p<0.01, 12h p<0.01). However from 1224 hours after TKA, the PAI group used significantly fewer rescue pain medications than
patients who received FNB (12h p=0.03, 18h p<0.01). When the total number of rescue
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analgesia was analyzed throughout the entire 48-hour period after surgery there were no
significant differences between groups. The duration of analgesia was shorter in patients
who received PAI (p<0.01) but motor paralysis of the ankle was significantly longer in
the FNB group (p<0.01). Investigators found no significant differences between the
groups in complications and patient satisfaction. In this study, patients in the FNB group
received their FNBs in combination with sciatic nerve block injections, which may
explain why pain scores favoured the FNB group in the early postoperative period up to
six hours. Furthermore, the number of functional measures reported in the early
postoperative period was limited and since this is the timeframe where PAI is expected to
be most effective, the study may have been unable to detect important differences.
Uesugi et al.15 concluded that single injection PAI provided a similar analgesic effect to
the combined use of sciatic and FNBs and since both techniques were administered as
single injections, continuous managements was not required. Furthermore, motor
paralysis in the PAI group was shorter which can lead to improved rehabilitation.
In 2013, Ashraf et al.10 conducted a similar randomized trial comparing single injection
PAI to single injection FNB. Overall 42 patients were randomized, 22 patients in the
FNB group (30mL 0.2% ropivacaine) and 20 patients in the PAI group (150mL 0.2%
ropivacaine/1 mL 1:1000 adrenaline/30 mg ketolorac). The primary outcome measure
was postoperative pain assessed by VAS at four hours postoperatively. Secondary
outcomes assessed were pain at two hours, pain at rest and after physiotherapy on
postoperative day one (POD1), total opiate use, length of stay, and functional outcomes.
All patients received PCA to assist in pain management. Results showed that at four
hours postoperatively patients in the PIA group (2.1±2.6) had significantly lower pain
scores than patients in the FNB group (6.8 ±3.2). This difference of 4.7 points was
statistically significant (p<0.01, 95% CI 2.8 to 7.5). There were no significant differences
in pain scores between the two groups at two hours post TKA. Pain at rest and after
physiotherapy on POD1 showed no significant differences between the two study groups.
However, patients in the PAI group consumed significantly less opiate analgesia during
their stay at the hospital compared to patients in the FNB group (p=0.01). There were no
significant differences between the two groups in functional outcomes and length of stay.
This study demonstrated that single injection PAIs provide better pain relief in the early
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postoperative period and overall lower use of opiate analgesia in comparison to single
injection FNBs. However, this study had a small sample size, surgeons were unblinded,
and less ropivacaine was used in the FNB group (30mL) as compared to the PAI
group(150mL). Furthermore, this study was underpowered in their assessments of
functional outcomes.
PAIs can be seen as advantageous to FNBs since special skills are not required to
administer the injection into the periarticular tissues. As Uesegi et al. described, the
analgesic effect is simply achieved by injecting the solution around the joint while being
careful to ensure that it does not enter a blood vessel15.

2.6.6.5  

Single  Injection  Periarticular  Injections  vs.  Continuous  
Femoral  Nerve  Blocks    

Various studies indicate that single injection PAIs offer equivalent analgesia to
continuous FNBs in the 48 hour postoperative period and similar side effects, while
providing better functional outcomes because of its absence of motor block41,79–81. In a
randomized trial conducted by Chaumeron et al.3, 60 TKA patients were randomized to
receive a single injection PAI (n=30) or continuous FNB (n=30). One patient in the PAI
group was excluded prior to surgery because of the inability to receive a spinal. More
patients in the FNB group experienced motor block, were unable to perform a straight leg
raises, and one patient experienced a fall requiring corrective surgery3. During this study
PCA was available for additional analgesia during the first 48 hours. In the PAI group,
the infiltration mixture consisted of 30mg ketorolac, 0.5mL adrenaline (1/1000), and 275
mg ropivacaine for a total mixture of 108mL and a simulated FNB to ensure blinding.
Patients randomized to the FNB group received an injection of 20mL ropivacaine and a
0.25% continuous infusion at 8-10mL/hour through a femoral catheter. The primary
outcome was morphine consumption with PCA during the first 48 hours after surgery.
Secondary measures assessed were daily pain scores (at rest and activity), length of stay,
motor blockage, and functional outcomes. Significantly higher morphine consumption
was observed from zero to eight hours after surgery in patients who received the FNB
(p=0.04). However, there was no significant difference between the two groups in
morphine consumption over the rest of the 48-hour postoperative period. No significant
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differences in postoperative pain were found between the two groups, however more
patients who received the continuous FNB group experienced motor block (11/30)
compared to patients in the PAI group (0/30) (p<0.001). On POD1, more patients in the
FNB group (6/27) compared to zero in the PAI group were unable to stand (p=0.018).
The proportion of patients unable to perform a straight leg raise on postoperative days
one to three was greater in the FNB group (p<0.001-0.002). Furthermore, patients in the
PAI group walked longer distances on POD zero, two, and three (p=0.004-0.031). A
similar number of complications were reported in each group. This study concluded that a
single injection PAI showed pain control similar to a continuous FNB while avoiding
motor block with its functional impact. This could be beneficial during the rehabilitation
period. Study patients in this trial did receive PCA over 48 hours, which could have
influenced pain score results. Furthermore, slightly more females were in the FNB group.
The sample size in this study was not large enough to accurately assess complication
rates. It also appears that not all patients completed postoperative functional outcomes
but this was not addressed in the discussion of the paper.
A small but potentially important increase in the rates of serious infection in patients
receiving continuous local infiltration through catheratization, was found in a metaanalysis conducted by Marques et al. within TKA patients73,80. Therefore, though FNBs
may negatively affect quadriceps function, are time-consuming, and are associated with
complications, it still remains the most commonly used peripheral nerve block method.
However, the potential and functional benefits of PAI versus FNB remain controversial
and are still being investigated3.

2.7   Summary  
The TKA is a surgical procedure that results in the best outcomes for osteoarthritis of the
knee. Postoperative TKA pain is severe and can negatively affect patient satisfaction,
functional outcomes, and the duration of hospitalization. Therefore, aggressive and
effective pain control during the early postoperative period is essential. Traditional
analgesic techniques such as PCA, epidurals, LPBs, and FNBs have been performed to
improve postoperative recovery. Though PCA using intravenous opioids and continuous
epidurals provide effective analgesia, they can be associated with side effects such as
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nausea, pruritus, vomiting, dizziness, urinary retention, sedation, poor muscle control,
and constipation. LPBs require advanced skills to perform and FNBs can negatively
affect quadriceps function increasing risks for inpatient falls.
Recently, studies that investigated adductor canal blocks have shown them to be effective
nerve blocks, providing adequate analgesia and sparing quadriceps strength in the early
postoperative period. More specifically, single injection adductor canal blocks do not
carry the risks associated with catheter use. Furthermore, using single injection
periarticular infiltrations as a regional block technique is simple to administer, spares
quadriceps strength, and provides adequate analgesia. FNBs are the most commonly used
blocks and studies consistently compare them to adductor canal blocks or periarticular
infiltration techniques. However, currently no clinical trial has directly compared
adductor canal blocks to periarticular infiltrations. Therefore, a randomized clinical trial
is needed to directly compare functional outcomes, pain, length of stay, and narcotic
consumption directly following a TKA between these two interventions.
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Chapter  3    

3  

Objectives    

Our primary objective was to compare the duration of analgesia following total knee
arthroplasty in patients who received periarticular infiltration to those who received a
motor sparing knee block. Our secondary objectives were to compare the two analgesic
techniques for the following outcomes: function using the Western Ontario McMaster
Osteoarthritis Index, Timed Up and Go, eligibility to perform physiotherapy, quadriceps
muscle power, length of hospital stay, and time to and length of first mobilization; pain
using a Numerical Rating Scale, time to rescue analgesia, total opioid consumption, and
site of predominant pain; quality of life using the Short Form 12; satisfaction, and side
effects.
We hypothesized that the motor sparing knee block would provide no difference in
analgesia duration compared to patients who receive periarticular local infiltration
analgesia following total knee arthroplasty. We also hypothesized that function, pain,
quality of life, satisfaction, side effects, and length of stay would be similar between the
two groups.
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Chapter  4    

4   Materials  and  Methods    
4.1   Study  Design  
This was a single-centre randomized clinical trial that took place in London, Ontario at
the London Health Sciences Centre (LHSC), University Hospital between July 2014 and
June 2015. The study involved patients undergoing a primary total knee arthroplasty
(TKA). The study was approved by the University of Western Ontario Research Ethics
Board for Health Sciences Research Involving Human Subjects (Appendix A).

4.2   Eligibility  Requirements    
Eligible patients were those between the ages of 18 and 85 years scheduled to undergo
elective primary TKA at the LHSC University Hospital, with good contralateral leg
strength and an ASA class between one and three. Patients were ineligible if they were
being hospitalized for reasons other than the planned surgery; had a psychiatric illness or
cognitive impairment that precluded them from giving informed consent or rendered the
patient unable to complete questionnaires; narcotic dependency; extraneous sources of
chronic pain; an allergy to any of the study drugs; any contraindications to blocks or
multimodal analgesia; patients who were wheelchair bound; patients with a language
barrier; or those unwilling to provide informed consent.

4.3   Subject  Recruitment    
Patients were recruited from the practices of four orthopaedic surgeons who specialize in
joint arthroplasty at the LHSC in London, Ontario.

4.4   Randomization  
Eligible patients were randomized via web-based software
(www.empowerhealthresearch.ca) prior to their TKA by one of two graduate students not
involved in the assessment of outcomes. The randomization contained mixed block sizes
of two and four and a one-to-one allocation ratio into either (1) motor sparing block
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(experimental) or (2) periarticular infiltration (control). Randomization was stratified by
gender and by surgeon.

4.5   Interventions  
4.5.1  Motor  Sparing  Block  (experimental  group)  
A pre-procedural scan performed by the anesthesiologist identified suitable locations to
perform the three major block injections. MSB blocks were performed in the PACU
block room using standard preoperative monitors including electrocardiogram (ECG),
pulse oximeter, and noninvasive blood pressure monitoring. Following sterile
precautions, the skin was anesthetized with 1% lidocaine. Patients were sedated during
the administration of the block with midazolam and fentanyl at the discretion of the
anesthesiologist performing the block. The MSB was performed under ultrasound
guidance in the supine position with the leg in external rotation. The MSB included 0.5%
ropivacaine, 2.5 ug/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac
giving a total anesthetic volume of 60 mL. The motor sparing block consisted of three
stages; the posterior peri capsular injection, adductor canal blockage, and lateral femoral
cutaneous injection to provide full knee analgesia.

4.5.1.1   Posterior  Peri  Capsular  Injection  
An eight-centimeter block needle was inserted near the medial femoral epicondyle (10
centimeters from the joint line) under ultrasound guidance. At this site, 20 mL of the
study drug was injected between the bone and popliteal artery. This constituted the
posterior peri capsular injection.

4.5.1.2   Adductor  Canal  Blockage  
The femoral artery was traced from the groin region under the sartorius muscle until the
superior geniculate artery was seen to take off from the femoral artery. The probe was
rotated 900 and moved superior tracing the sartorius and the femoral artery eight to ten
centimeters proximally in the long axis. This was marked as the second needle entry
point for injection of the intermediate cutaneous nerve. The intermediate cutaneous nerve
of thigh usually travels as a dual nerve between the sartorius and rectus femoris above the
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fascia lata, which was identified at this point. An eight-centimeter block needle was
inserted out of plane with the artery in short axis under the sartorius at the pre-marked
site. Between the sartorius and rectus femoris muscles, 5 mL of study drug was injected
to target the intermediate cutaneous nerve of the thigh. For this injection the needle was
inserted from a lateral to medial direction with the needle tip lying superficial to the
fascia lata. The needle was redirected to enter the fascia of the sartorius to deliver an
additional 5 mL of the study drug. The needle was then advanced until the needle tip was
seen to lie adjacent to the femoral artery under the sartorius within the adductor canal.
Following this, 20 mL of the study drug was injected, while watching for confirmation of
the study drug deposition around the femoral artery. A block catheter was inserted three
centimeters beyond the tip of the needle under ultrasound guidance. Colour Doppler was
used to confirm that the catheter tip was in the proper location (close to the femoral
artery). Therefore, a total of 30 mL of the study drug solution was used in the adductor
canal blockage.

4.5.1.3   Lateral  Femoral  Cutaneous  Injection    
Following the adductor canal block, the sartorius was traced to its origin at the anterior
superior iliac spine. The lateral cutaneous nerve of thigh was blocked in the lacuna
musculorum between the origin of sartorius and tensor fascia lata muscle with the final
10 mL of the study drug. Therefore, a total study drug volume of 60 mL was used. Sham
periarticular injections of isotonic saline (100 mL) were administered intraoperatively to
blind both the surgeon and anesthesiologist.

4.5.2  Periarticular  Infiltration  (control  group)  
Patients randomized to the control group had isotonic saline (60 mL) injected during the
preoperative performance of the MSBs to ensure blinding. These patients received
periarticular infiltration of local anesthetics. This 100 mL mixture consisted of 0.3%
ropivacaine, 2.5 µg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac
administered by the surgeon at the end of surgery as per usual practice at LHSC. The first
20 mL aliquot of the mixture was injected into the posterior aspect of the capsule and the
medial and lateral collateral ligaments just prior to implantation of the component. Care
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was taken around the area of the common peroneal nerve during this process. The
quadriceps mechanism and retinacular tissues were then infiltrated with an additional 20
mL of the study drug. Finally, the remaining 60 mL was used to infiltrate the fat and
subcuticular tissues.

4.5.3  Standardization  of  Potential  Co-interventions  
All study patients received preoperative multimodal analgesia of Tylenol (975mg),
Naproxen (500mg), Gabapentin (600mg), and Granisetron (2mg). All TKA’s were
posterior stabilized using one of the following implants; Attune, Triathlon, or Genesis II.
Patellar resurfacing was performed at the discretion of the surgeon. Surgery was
performed in a bloodless field using a femoral tourniquet. At the end of surgery, the
surgeon applied compression bandages covering the entire knee. All patients received
spinal anesthesia with 15 mg of hyperbaric bupivacaine with titrated sedation
intraoperatively at the discretion of the anaesthesiologist.
Following surgery the inpatient drug regimen was standardized. Infusion of local
anesthetics into the catheter was initiated once patients reported pain of 6/10 or higher on
the VAS pain scale. This started with a 10 mL bolus of 0.2% ropivacaine and subsequent
infusion at a basal rate of 6 mL/hour with patient controlled boluses (PCRA) of 4 mL
every 30 minutes as need. This ensured prolonged analgesia once the single injection
MSB or PAI interventions stopped providing adequate pain relief. Secondary rescue
analgesia consisted of five to ten milligrams of oxycodone as needed if pain was still
poorly controlled. All patients were seen twice a day by ward physiotherapists as per
standard protocol.

4.6   Blinding  
An independent anesthesiologist (SG) who was not involved in administering the study
interventions or conducting outcomes assessments prepared and concealed the study
drugs from the outcome assessors and the anesthesiologists responsible for performing
the motor sparing blocks, and the orthopaedic surgeons performing the infiltrations. An
independent nurse not involved in the study measured the block characteristics. Therefore
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the patient, surgeon, block anesthesiologist, and outcome assessor all remained blinded.
Block mixtures and isotonic saline are visually indistinguishable. Furthermore, the
containers were identical in appearance. Patients who were randomized to receive
preoperative motor sparing blocks (MSB) received intraoperative periarticular
infiltrations (PAI) with isotonic saline. Patients who were randomized to receive PAIs
received preoperative MSBs with isotonic saline.

4.7   Outcome  Measures  
All patients were measured preoperatively, every day during their inpatient stay until
discharge, and at three months postoperatively.

4.7.1  Primary  Outcome  Measure    
The primary outcome in this study was duration of analgesia. This was measured using a
numeric pain rating scale (NPRS). The NPRS is an 11-point interval scale from zero (no
pain) to ten (worst pain imaginable). A review paper by Williamson et al.82 indicated that
the 11-point interval scaled NRPS has a high sensitivity to change; is reliable, valid, and
easy to administer. Time zero was defined as the end of the administration of the MSB by
the anaesthetist or completion of PAI by the surgeon. Patients were assessed for pain
during rest and activity (45 degrees of flexion) at baseline, upon arrival in PACU, and
then at two, four, six, 12, 18, 24, 30, 36, and 48 hours. If patients were not discharged at
or before 48 hours, pain was assessed at 72 hours. If patients were discharged before 48
hours, the research assistant telephoned the patient and asked them to verbally report their
pain scores at 48 hours.
The end of analgesia was defined as patient reported pain equal to or more than 6/10 on
the NRPS. Additional studies have used pain equal to or more than 6/10 on the NRPS as
an indicator for severe pain as well 11,59. The first rescue analgesia was the initiation of
the continuous ACB (10 mL bolus of 0.2% ropivacaine and subsequent infusion at a
basal rate of 6 mL/hour with patient controlled boluses of 4 mL every 30 minutes as
needed) by the bedside nurse for the purpose of controlling pain. We reported the
proportion of patients who were discharged prior to starting the first rescue analgesia.
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4.7.2  Secondary  Outcome  Measures    
4.7.2.1   Quadriceps  Muscle  Strength  
We measured maximum voluntary isometric contraction (MVIC) with a hand held
dynamometer (JTECH Medical; Commander Echo Muscle Testing Dynamometer) before
and 20 minutes after the administration of the blocks. Hand held dynamometers are
considered reliable and valid instruments83. After surgery, we repeated this measurement
at six hours after the initial block, and 0800 hours and 1600 hours daily until the
resolution of the initial block evidenced by NPRS pain equal to six or higher.
We evaluated quadriceps muscle strength with the patient in a seated position on the edge
of the bed. The knee was flexed approximately 60 degrees with both feet hanging. The
hand held dynamometer was placed perpendicular to the tibial crest five centimeters
proximal to the medial malleolus as described by Grevstad et al.11. For each assessment,
three measurements were done with a five second pause between measurements. We
recorded the maximum value out of the three.

4.7.2.2   WOMAC  
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a
widely used measure of symptoms and physical disability which was originally
developed for patients with OA of the hip or knee84. It evaluates clinically important and
patient-relevant changes in health status as a result of treatment interventions. The
WOMAC evaluates three dimensions: pain, stiffness, and physical function with five,
two, and seventeen questions, respectively85. For our study we used the Likert version of
the WOMAC. Each question is rated on an ordinal scale of zero to five and is associated
with descriptors; zero (none), one (mild), two (moderate), three (severe), and four
(extreme). All three sections of WOMAC are summed together and the total score
indicates the severity of the patients’ pain (0-20), stiffness (0-8), and physical disability
(0-68). A higher WOMAC score indicates worse pain, stiffness, and physical
functionality in the individual.
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McConnell et al.84 conducted a literature review to assess the reliability, validity, and
responsiveness of the WOMAC using 43 extracted articles. While assessing the reliability
in a drug trial using the Likert WOMAC they found an internal consistency of the pain
subscale to be 0.86, 0.90 for stiffness, and 0.95 for physical function. Consistent
responsiveness was found for all subscales. They concluded that the WOMAC is valid,
reliable, and sensitive for use in TKA trials. Marsh et al.86 found excellent agreement
between the paper and electronic versions of the WOMAC (WOMAC ICC= 0.96, 95%
CI 0.94 to 0.98) concluding that online data collection may be substituted for the
traditional paper method with no significant effect on the validity of the questionnaires.
In our study, patients completed the WOMAC questionnaire at baseline and again at three
months postoperatively. For our results, higher WOMAC scores indicate improved pain,
stiffness, and physical functionality.

4.7.2.3  

SF-12  Health  Survey  (SF-12)  –  version  2  

A shortened version of the SF-36, the SF-12 health survey, is a patient reported survey
that assesses general health. The SF-12 consists of two questions concerning physical
function, two questions on role limitations because of physical health problems, one
question on bodily pain, one question on general health perceptions, one question on
vitality (energy/fatigue), one question on social functioning, two questions on role
limitations because of emotional problems, and two questions on general mental health87.
These eight weighted sections are each transformed onto a scale of zero to 100 where
zero indicates the worst disability. The SF-12 health survey has been proven to be a valid,
reliable, and responsive outcome measure.88 Study patients completed the SF-12
questionnaire at baseline and again at three months postoperatively.

4.7.2.4  

Physiotherapy  and  Mobilization      

We recorded when patients reached eligibility to perform their first inpatient
physiotherapy appointment following TKA. Furthermore, time to first mobilization and
pain on the NPRS following every physiotherapy appointment was recorded. For our
study, only a walking distance greater than five meters was considered patient

48

mobilization. We recorded length of the first mobilization and if a study patient was
unable to perform physiotherapy.

4.7.2.5  

Total  Opiate  Consumption  

We recorded the time each rescue medication was received, dose, and frequency. If poor
pain control persisted after the first two rescues (ACB and oxycodone), the ward nurse
administered Hydromorph Contin; the same data was recorded (time, dose and
frequency) by accessing the patients’ medication administration record.

4.7.2.6  

Timed  Up  and  Go  Test  

The timed up and go (TUG) test is a valid and reliable test (ICC=0.80, 95% CI: 0.70,
0.94) to evaluate patients on an orthopaedic rehabilitation ward on skills in functional
mobility89,90. The TUG test consists of recording the time it takes for an individual to get
up from a chair, walk at a comfortable pace to a three-metre mark, turn around, come
back, and sit back down91. The chair used in all tests was standardized and the assistive
device used by the study patient during the test was recorded. All patients attempted to
perform the TUG test during the first physiotherapy appointment on postoperative day
one (POD1) and again at discharge. If a patient was unable to perform the test it was
recorded and the reason documented.
According to Podsialdo et al.91 TUG tests indicate the patients’ level of physical
mobility. Specifically, independent individuals can perform the test in less than ten
seconds. Individuals who perform the test in ten to 20 seconds are within normal limits
for frail elderly patients. Finally, patients who take 30 seconds or more to complete the
test, require assistance from others for many mobility tasks.

4.7.2.7  

Site  of  Predominant  Pain  

During each pain assessment (two, four, six, 12, 18, 24, 30, 36, 48, and 72 hours if
needed) patients were asked to indicate where on their knee they felt the most intense
pain.
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4.7.2.8  

Side  Effects  

During each assessment until discharge (two, four, six, 12, 18, 24, 30, 36, 48, and 72
hours if needed) we recorded intensity of nausea and incidence of pruritus. Patients used
a four-point scale to evaluate nausea at each time point (0= no nausea or vomiting,
1=nausea no vomiting, 2=vomiting, 3=persistent vomiting)53,13,62,92 and pruritus (yes or
no).

4.7.2.9  

Length  of  Hospital  Stay    

We recorded the number of days until patients reached discharge eligibility. Patients were
discharged by their attending surgeon and physiotherapist when pain and nausea were
controlled, there was an absence of medical or surgical complications, and if they were
mobile and able to manage stairs.

4.7.2.10   Patient  Satisfaction    
Study patients were given a satisfaction form to complete when discharge eligibility was
achieved and again at three months postoperative. This form included the patient
satisfaction section from the post-operative Knee Society Score (KSS) questionnaire and
an additional question that recorded the patients’ overall satisfaction with their
postoperative pain control using a NRS from zero (very poor) to ten (very good)13,93. The
KSS is a validated and reliable questionnaire that combines an objective physicianderived component with a subjective patient-derived component that evaluates pain
relief, functional abilities, satisfaction, and fulfillment of expectations94,95. The patient
satisfaction section contains five questions on a forty-point scale.

4.7.2.11   Patient  Characteristics  and  PACU/Block  Room  Details  
Preoperatively, we collected demographic information including birthdate, operative
knee, gender, height, weight, BMI, comorbidities, and usual pain medications. While the
patients were in the PACU and block room, the research team collected details including
date of surgery, ASA score, block sedation requirement, pre-op pain score (rest/activity),
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pre-op multimodal drugs given, block performance time, number of injection attempts,
block failure, colour doppler, time of intraoperative infiltration, block sensation testing,
patient proprioception, time of spinal recession, and intra-operative analgesics.

4.8   Sample  Size  
According to Zhang et al.16 the duration of analgesic effect from single injection PAI
(control group) can range from eight to 24 hours. In an unpublished pilot study, clinicians
at LHSC claimed experiencing a mean duration (±SD) of single injection PAI analgesia
to be approximately 16 (±5.5) hours. They also defined the minimally important
difference between groups in analgesic duration to be four hours. Clinicians at LHSC
chose this number based on their experiences since it was not available in the literature.
We conducted a formal equality sample size calculation using a two-sided alpha error
rate of 0.05 with a statistical power of 80% to detect a minimally important difference
between groups of four hours. We used the pre-determined standard deviation of ±5.5
hours in this calculation. This required approximately 30 patients to each group. We
expected a 20% dropout rate. Therefore, we chose to recruit 80 patients for the trial, 40 to
each group.

4.9   Data  Analysis  
We analyzed all patients according to the treatment arm they were assigned to (intentionto-treat). We used SPSS version 23.0 to perform the analysis of the data. We used
descriptive statistics to present the demographic characteristics of each group using
means and standard deviations for continuous variables (age, height, weight, and BMI)
and proportions for nominal variables (sex, operative knee, ASA score, tourniquet time,
and medications).
We used an analysis of covariance (ANCOVA) to statistically compare the two groups
for total duration of analgesia, quadriceps strength, WOMAC, time to eligibility for
physiotherapy, time to and length of first mobilization, time to complete the TUG tests,
SF-12, length of stay, satisfaction, opiate consumption, and physiotherapy pain. The
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outcome served as the dependent variable, group allocation served as the independent
variable and pain and tourniquet time as the covariate. Baseline scores were used as
covariates for WOMAC and SF-12. If the data was not normally distributed we used the
Mann-Whitney U test to statistically compare the groups. A Bonferroni correction was
used to correct for multiple comparisons.
We reported the unadjusted mean with 95% confidence intervals in figures and the
adjusted mean with standard error and the adjusted mean difference between groups with
95% confidence intervals in tables and text. We used the last outcome carried forward
(LOCF) method in patients whose final pain score was missing (n=3).
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Chapter  5    

5  

Results  

5.1   Participant  Flow    
The flow of patients through each stage of the study is outlined in Figure 5. From July
2014 to March 2015, we screened 334 patients for this study. Of these, 138 patients were
ineligible, 16 were missed, 22 declined to participate, and 59 were enrolled in other
studies. Several patients were excluded for more than one reason.
Eighty-eight eligible patients gave their consent to participate in the study. Five patients
were withdrawn prior to being randomized for surgery; four patients decided not have to
surgery during the study time and one patient was rescheduled without study assessors
being notified. Twelve patients were withdrawn after being randomized. Of these, five
withdrew consent because they no longer wanted to undergo a spinal anesthetic, three
patients withdrew because they felt the risks associated with undergoing a block were too
high, one patient rescheduled their surgery outside of the study period, there was
insufficient time to perform the intervention for one patient, and for two patients first
rescue was erroneously initiated immediately post surgery. At the time of this analysis,
54 patients had reached the three-month study end point. Patient demographics and
comorbidities were similar between groups (Table 1).
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Assessed for Eligibility (n=334)

Eligible (n=87)

Pre-randomization
withdrawal (n=5)

Randomized
(n=82)

Motor Sparing
Knee Block (n=41)

Periarticular
Infiltration (n=41)

Withdrawn at
hospital visit (n=6)

Withdrawn at
hospital visit (n=6)

Included in hospital
stay analysis (n=35)

Included in hospital
stay analysis (n=35)

Reached 3 months
(n=24)

Reached 3 months
(n=30)

Included in 3 month
analysis (n=24)

Included in 3 month
analysis (n=30)

Figure 5: Participant flow through study
Some patients ineligible for more than one reason.

Ineligible (n=138)
Age (n=4)
Not scheduled to undergo primary TKA
(n=11)
Significant contralateral leg weakness
(n=19)
Planned hospitalization for other reasons
(n=1)
Psychiatric illness (n=9)
Revision surgery (n=1)
Narcotic dependency (n=4)
Pre-existing chronic pain (n=18)
Study drug allergies (n=26)
Contraindications to blocks (n=63)
Wheelchair bound (n=4)
Language barrier (n=7)
Enrolled in another study (n=59)
Cancelled appointment (n=11)
Declined to participate (n=22)
Missed (n=16)
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Table 1: Baseline Demographics for patients undergoing total knee arthroplasty with
either the motor sparing block or periarticular infiltration techniques
Characteristic

Motor Sparing
Knee Block
(n=41)
13 (31.7)
68±8
165 ±10
95±22
34.6±7.7
25 (61)

Periarticular Infiltration
(n=41)

Male, n (%)
15 (36.6)
Mean Age ± SD, y
63±9
Mean Height ± SD, cm
167 ±10
Mean Weight ± SD, kg
91±21
2
Mean BMI ± SD, kg/m
32.4±7.1
Operative Knee, Right n (%)
25 (61)
ASA Status, n (%)
One
2 (4.9)
0 (0)
Two
23 (56.1)
26 (63.4)
Three
16 (39.0)
15 (36.6)
Tourniquet Time ± SD, min
70.2 ± 14.5
64.6 ± 10.5
Pre-Surgical Pain Medications, n (%)
NSAIDS
22 (53.7)
20 (48.8)
Pain Killers
23 (56.1)
18 (43.9)
Narcotics
10 (13.7)
8 (19.5)
Abbreviations. SD = standard deviation, BMI = body mass index, ASA = American Society
of Anesthesiologists physical status classification system, MSB=motor sparing block, PAI=
periarticular infiltration
The time to perform the block and method of sedation were similar between groups as were
other means of intraoperative pain management (Table 2).
Table 2: Block characteristics for patients undergoing total knee arthroplasty with
either the motor sparing block or periarticular infiltration techniques
Block Characteristics

MSB (n=35)

PAI (n=35)

MSB Performance Time ±SD, min
10.09 ± 3.76
10.74 ± 4.64
Block Sedation
Fentanyl ± SD, ug
85.0 ± 41.2
88.2 ± 35.2
Midazolam ± SD, mg
1.75 ± 0.38
1.53 ± 0.38
Intraoperative Propofol ± SD, mg
196.6 ± 113.4
197.1 ± 99.5
Postoperative Spinal Length ± SD, hrs 1.33 ±1.03
1.06 ±0.82
Spinal Failure, n (%)
1 (3)
1 (3)
Abbreviations. SD = standard deviation, MSB=motor sparing block, PAI= periarticular
infiltration
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5.2  

Primary  Outcome  Measure  

5.2.1   Total  Duration  of  Analgesia    
There was a statistically significant difference between groups in the total duration of
analgesia during hospitalization (8.8 hours (95% CI 3.98 to 13.62), p<0.01) in favour of the
MSB with a mean duration of 18.06 ±1.68 hours compared to the PAI group with a mean
duration of 9.25 ± 1.68 hours. The distribution of the PAI group was more skewed towards
lower duration hours in comparison to the MSB group with lines representing mean values
(Figure 6).
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Figure 6: Total duration of analgesia following total knee arthroplasty with either the
motor sparing block or periarticular infiltration block techniques (dark line:
medians)
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5.3  

Secondary  Outcome  Measures  

5.3.1   Overall  Pain  
5.3.1.1   Pain  at  Rest    
There was a statistically significant difference in mean pain scores at rest at two hours
postoperative. There were no significant differences at any other time points (Figure 7).
Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI n=9).

Figure 7: Numerical rating pain scores at rest following TKA with either the motor
sparing block or periarticular infiltration block techniques (unadjusted
means, 95% confidence intervals)

5.3.1.2   Overall  Pain  During  Activity    
There was a statistically significant difference in pain scores during activity at two and four
hours postoperative. There were no significant differences at any other time points (Figure
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8). Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI
n=9).

Figure 8: Numerical rating pain scores during activity following TKA with either the
motor sparing block or periarticular infiltration block techniques
(unadjusted means, 95% confidence intervals)

5.3.2   Quadriceps  Muscle  Strength    
Because quadriceps strength was measured at baseline, 20 minutes and six hours after the
administration of blocks, and at 0800 hours and 1600 hours daily until the first rescue
analgesic was received, some patients completed a greater number of muscle tests than
others because of different rescue times. During the study period no patient required muscle
testing after 0800 hours on postoperative day two because they had been discharged from
hospital.
There were also no statistically significant differences for quadriceps muscle strength in
pounds of force between groups preoperatively (adjusted mean difference -1.23 (95%CI 9.14 to 6.61), p=0.75) or at 20 minutes (adjusted mean difference -0.41 (95%CI -7.60 to
6.78), p=0.91) and 6 hours postoperatively (adjusted mean difference -1.23 (95%CI -6.8 to
4.3), p=0.66) (Figure 9). No significant differences were found at further time points.
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Figure 9: Quadriceps muscle strength in pounds of force following total knee
arthroplasty with either the motor sparing block or periarticular infiltration
block techniques (unadjusted means, 95% confidence intervals)

5.3.3  

Western  Ontario  McMaster  Osteoarthritis  Index  

There were no statistically significant differences between the groups at baseline or three
months for the pain, stiffness, and function domains. Furthermore, no significant differences
were found between the groups at baseline or three months for the total WOMAC score
(Table 3). Both groups improved from baseline to three months postoperative.
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Table 3: Western Ontario McMaster Osteoarthritis Index scores following total knee
arthroplasty with either the motor sparing block or periarticular infiltration block
techniques (adjusted means)
Time

Domain

MSB
PAI
Adjusted Mean
p-Value
(mean ± SE)
(mean ± SE)
Difference (95% CI)
Preop Pain
54.2 ± 3.09
48.5 ± 2.64
Stiffness
42.2 ± 4.11
39.2 ± 2.86
Function
51.2 ± 3.58
50.1 ± 2.68
Total
50.5 ± 3.07
47.1 ± 2.38
3m
Pain
77.8 ± 3.23
72.7 ± 2.88
-5.08 (-13.8 to 3.7)
0.25
Stiffness
62.7 ± 3.99
57.3 ± 3.57
-5.41 (-16.2 to 5.4)
0.32
Function
75.0 ± 3.14
72.1 ± 2.81
-2.87 (-11.4 to 5.6)
0.49
Total
73.3 ± 2.75
69.5 ± 2.46
-3.80 (-11.2 to 3.6)
0.31
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block,
PAI= periarticular infiltration

5.3.4  

SF-12  Health  Survey  (SF-12)  –  version  2  

There were no statistically significant differences found between the groups at baseline or
three months for the physical or mental components (Table 4). Both groups improved from
baseline to three months for the physical component.
Table 4: SF-12 Health Survey scores following total knee arthroplasty with either the
motor sparing block or periarticular infiltration block techniques (adjusted
means)
Time

Domain

MSB
PAI
Adjusted Mean
p-Value
(mean ± SE)
(mean ± SE)
Difference (95% CI)
Preop Mental
57.9 ± 2.02
54.0 ± 1.96
Physical
31.5 ± 1.56
32.2 ± 1.71
3m
Mental
51.9 ± 1.67
55.1 ± 1.48
3.16 (-1.24 to 7.65)
0.17
Physical
43.5 ± 1.53
39.8 ± 1.37
-3.75 (-7.87 to 0.37) 0.07
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block,
PAI= periarticular infiltration
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5.3.5  

Physiotherapy  and  Mobilization    

5.3.5.1   Time  to  Eligibility  for  Physiotherapy    
The time it took patients to reach eligibility to perform their first inpatient physiotherapy
following TKA was not significantly different between the groups (0.34 hours (95% CI 1.37 to 2.05), p=0.69). It took patients in the MSB group a mean of 20.7 ± 0.59 hours and
patients in the PAI group a mean of 20.4 ± 0.59 hours.

5.3.5.2   Time  to  First  Mobilization  
The length of time it took patients to mobilize for the first time following TKA was not
significantly different between groups (2.2 hours (95% CI -4.2 to 8.6), p=0.49). It took
patients in the MSB group a mean of 27.3 ± 2.23 hours and patients in the PAI group a mean
of 25.0 ± 2.23 hours.

5.3.5.3   Length  of  First  Mobilization    
The length of first mobilization following TKA was not significantly different between
groups (0.5 meters (95% CI -0.69 to 1.71), p=0.40). Patients in the MSB group mobilized
for a mean of 8.23 ± 0.42 meters compared to patients in the PAI group who mobilized for a
mean of 8.74 ± 0.42 meters.

5.3.5.4   Physiotherapy  Pain  
The number of patients remaining in hospital decreased over time. Thus, the number of
patients participating in inpatient physiotherapy also decreased. Other than being
discharged, two patients in the PAI group did not undergo physiotherapy on the morning of
postoperative day one (too nauseous); three patients did not participate in physiotherapy on
the afternoon of postoperative day one (significant pain (n=2) and no physiotherapist
available (n=1)); one did not perform physiotherapy on the morning of day two (too
nauseous). There was no difference between groups for the amount of pain immediately
following each physiotherapy appointment (Figure 10).
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Figure 10: Pain following postoperative physiotherapy appointments following total
knee arthroplasty with either the motor sparing block or periarticular
infiltration block techniques (unadjusted means, 95% confidence intervals)

5.3.6  

Total  Opiate  Consumption    

There were no differences in total oxycodone consumption (Figure 11) or total
hydromorphone consumption (Figure 12) between the two groups at any time point.
Eighteen patients remained in the hospital at the 72 hour time point (MSB n=9, PAI n=9).
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Figure 11: Oxycodone consumption following total knee arthroplasty with either the
motor sparing block or periarticular infiltration block techniques
(unadjusted means, 95% confidence intervals)

Figure 12: Hydromorphone consumption following total knee arthroplasty with either
the motor sparing block or periarticular infiltration block techniques
(unadjusted means, 95% confidence intervals)
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5.3.7  

Timed  Up  and  Go  Test  

A total of 18 study patients could not perform the TUG test on postoperative day one. Eight
of these patients were in the MSB group and ten were in the PAI group. One patient in the
PAI group used crutches to complete the test while all patients in the MSB group used a
walker. No statistically significant differences were found between groups for time to
complete the TUG on postoperative day one (Table 5).
One patient in the MSB group refused to perform the TUG test at discharge because of
muscle weakness and a fear of falling. Four patients in the PAI group used crutches to
complete the test while all patients in the MSB group used a walker. No statistically
significant difference was found between groups for time to complete the TUG at discharge
(Table 5).
Table 5: Time to Complete the Timed Up and Go in seconds following total knee
arthroplasty with either the motor sparing block or periarticular infiltration
block techniques (adjusted means)
Time

MSB
(mean ±SE)
66.16 ±3.52

PAI
(mean ± SE)
58. 48 ± 3.66

Adjusted Mean
Difference (95% CI)
-7.69 (-17.92 to 2.54)

p-Value

Day 1
0.14
nMSB=27,nPAI=25
Discharge
50.21 ±3.68 47.51 ± 3.62 -2.69 (-13.02 to 7.63)
0.60
nMSB=34, nPAI=35
Abbreviations. SE = standard error, CI = confidence interval, MSB=motor sparing block,
PAI= periarticular infiltration

5.3.8  

Site  of  Predominant  Pain  

There was no statistically significant relationship between group allocation and site of
predominant pain at any of the time points. Nine patients in the MSB group and nine
patients in the PAI group remained in the hospital at 72 hours. From arrival in PACU to two
hours postoperative most patients did not report pain in their knee. At four hours
postoperative, approximately half of the MSB group reported pain at the front of their knee
whereas the other half still reported no pain. At this same time, about a quarter of the PAI
patients reported pain at the front of their knee, another quarter reported pain at the back of
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the knee whereas about half still reported no pain. From six hours postoperative until
discharge the most common site of predominant pain for each group was at the front of the
knee.

5.3.9  

Side  Effects  

5.3.9.1   Nausea  
There were no differences in nausea scores between treatment groups from zero to 72 hours
(Figure 13).

Figure 13: Nausea scores following total knee arthroplasty with either the motor
sparing block or periarticular infiltration block techniques (unadjusted
means, 95% confidence intervals)

5.3.9.2   Pruritus    
There was no difference between groups for pruritus at any of the time points. At majority of
time points, no patients reported pruritus.
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5.3.10   Length  of  Hospital  Stay  
The length of hospital stay following TKA was not significantly different between groups
(0.23 days (95% CI -0.19 to 0.66), p=0.29). Patients in the MSB group had a mean hospital
stay of 2.39 ± 0.15 days compared to patients in the PAI group who had a mean hospital stay
of 2.17 ± 0.15 days.

5.3.11   Satisfaction  
Overall NRS satisfaction with overall pain control from surgery until discharge was not
significantly different between groups at discharge (adjusted mean difference -0.20 (95%CI
-1.62 to 1.22), p=0.77). KSS satisfaction scores were also not significantly different between
groups at discharge or three months (Table 6).
Table 6: Knee Society Score Satisfaction following total knee arthroplasty with either
the motor sparing block or periarticular infiltration block techniques
(adjusted means)
Time
Discharge
3m

5.4  

MSB
(mean ±SE)
21.2 ± 0.92
28.4 ± 1.43

PAI
(mean ± SE)
20.2 ± 0.86
28.6 ± 1.33

Adjusted Mean
Difference (95% CI)
0.23 (-371 to 4.17)
0.05 (-0.95 to 1.05)

p-Value
0.91
0.93

    Adverse  Events    

Three adverse events occurred during this study; two in the MSB group and one in the PAI
group. One patient in the MSB group suffered a deep vein thrombosis (DVT) that delayed
their discharge from the hospital. A second patient in the MSB group was admitted to
emergency for shortness of breath within the three-month study period after their initial
discharge following TKA. They were discharged from the emergency room with suspected
interstitial lung disease. One patient in the PAI group fell on the day after surgery attempting
to get out of bed without assistance. This event did not affect the patients’ rehabilitation and
they were discharged without delay on day two from the hospital.
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Chapter  6  

6  

Discussion  

We aimed to compare the duration of analgesia following total knee arthroplasty in
patients who were randomized to receive either periarticular infiltration (control group)
or a motor sparing knee block (experimental group). We also assessed postoperative
function, pain, satisfaction, opiate consumption, and side effects. We found a statistically
significant difference in favour of the motor sparing block (MSB) group for total duration
of analgesia and early pain scores during rest and activity (2 to 4 hours) were
significantly lower in the MSB group. No significant differences were found between
treatment groups for any other outcome.
Currently, femoral nerve blocks (FNB) are the gold standard peripheral nerve block for
TKA at most centers around the world33. At our center however, PAI is the standard
postoperative analgesia because it spares quadriceps function thereby facilitating
rehabilitation and a shorter length of stay. PAI does not however, offer the duration of
analgesia offered by a FNB15. On the other hand adductor canal blocks (ACB) minimally
affect quadriceps function but are technologically more challenging than the PAI and
require ultrasound guidance like the FNB. To date there is one study showing greater
early postoperative pain relief in favour of FNB1 and six studies showing no difference11–
14,20,96

. There are no studies that demonstrate greater pain relief for the ACB over the

FNB.
For our study, we created the MSB that is essentially an ACB with the addition of
injected analgesia at the posterior and lateral knee joint (posterior periscapular and lateral
femoral cutaneous nerve injection) with the goal of providing pain relief for more regions
around the knee joint. Since no study has ever reported duration of ACB, we were
uncertain whether our MSB would provide a greater duration of pain relief compared to a
PAI. We did not expect to find differences in quadriceps strength or function between
MSB and PAI since both techniques retain quadriceps function. Our longer term goals
are to enhance the MSB by adding a sedative as an adjuvant to prolong the duration of
analgesia and avoid the use of the catheter required for continuous infusion blocks.
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There are no published studies comparing single injection ACBs, which are most similar
to our MSB technique, to single injection PAI. However, numerous trials have compared
either single or continuous PAI to FNBs3,10,41,79–81. For example, Uesugi et al.15
randomized 210 patients to either single injection PAI or FNB with an additional sciatic
block (FNB group). The drug mixture used in their PAI group was similar in class and
dose to the mixture used in our study. This study was unique in that they also measured
the duration of analgesia for their treatment groups as we did. They reported that the
onset of pain in patients who received the PAI was 8.4 ± 9.2 hours post block which is
similar to our patients who received PAI whose onset of pain was 9.25 ± 10.3 hours post
block. They demonstrated that the duration of analgesia for patients who received a
femoral nerve block (FNB) was longer than those who received a PAI (15.3 ± 8.4 hours).
Given this finding and the similarity between FNB and MSB (both peripheral nerve
blocks), we expected the patients who received the MSB to experience a greater duration
of pain relief than patients who receive a PAI. In fact, our MSB patients did not require
their first rescue medication for an average of 18.1 ± 10.1 hours post block. Both groups
in our study reported a longer duration of analgesia than the patients in the Uesugi study,
which may be partially explained by the difference in method to measure time to first
rescue. Whereas in the Uesugi et al study patients were instructed to press a call button
when they felt postoperative pain, in our study patients were required to indicate a pain
score equal to or greater than six on a pain NRS, which may have meant that our patients
experienced a greater level of pain before being provided with rescue medication.
In our study, once patients reached NRS pain greater than or equal to six, the continuous
infusion (first rescue) was started to reduce pain scores. Since this was standardized
amongst all study patients, we were uncertain whether there would be a difference in
NRS pain scores at rest or activity from arrival in PACU until discharge because no study
has ever reported duration of pain relief for an ACB. What we were able to show,
however, was that there was a statistically significant difference for postoperative pain
scores at two and four hours during activity and at two hours during rest in favour of the
MSB group with no significant differences at any other time points. This finding is likely
explained by the shorter duration of pain relief (wearing off for most patients by the first
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eight hours) for the PAI with increasing pain in these patients until first rescue compared
to maintained pain relief in patients who received the MSB.
Studies have shown that ACBs retain quadriceps strength to a greater extent than FNBs
because of the minimal blocking of motor nerves in the ACB procedure. Only the nerve
to vastus medialis is blocked in the ACB. For example, Kim et al.13 hypothesized that a
single injection ACB would be superior in quadriceps strength to the FNB in their
randomized trial. Strength was assessed with a hand held dynamometer at six to eight
hours, 24, and 48 hours postoperative. They reported superior quadriceps strength in the
ACB group at six to eight hours postoperative and no significant differences at 24 or 48
hours. Similarly, Grevstad et al.11 randomized 50 patients to receive either a single
injection ACB or single injection FNB. Quadriceps strength was assessed at two hours
post block. They reported 20% greater quadriceps strength in the ACB group compared
to the FNB group. Finally, Jaeger et al.92 randomized 54 patients comparing continuous
ACB to continuous FNB. They assessed quadriceps strength preoperatively and at 24
hours postoperatively. Their results indicated significantly greater quadriceps strength in
the ACB group compared to the FNB group. On the other hand, Wang et al.78 conducted
a meta-analysis on 10 RCTs comparing PAIs and FNBs. Three studies indicated that the
number of patients able to do active straight leg raises at 24 hours following TKA was
significantly larger in the PAI group. Since the two additional injections used in our MSB
do not target any additional motor nerves, we did not expect to see any differences
between the MSB and PAI for quadriceps strength in our study.
In our study, muscle strength was only assessed until the first rescue analgesia was
received (pain ≥6). This gave us the ability to directly attribute the quadriceps strength
results to either the MSB or PAI instead of MSB or PAI in combination with any rescue
medication. As expected, no statistically significant differences were found between
groups at any time for quadriceps strength. The number of individuals at each time point
who had not received the first rescue decreased faster in the PAI group than the MSB
group. Only two patients in the MSB group and one patient in the PAI group never
required rescue medication prior to discharge.
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In addition to investigating postoperative quadriceps strength in nerve block studies,
physiotherapy milestones should also be assessed to give a more accurate representation
of a patient’s overall functional recovery prior to discharge13. In our sample, we did not
observe differences between groups in time to be eligible to begin physiotherapy (i.e.
pain control, no nausea) or time to and length of first mobilization. This strengthens our
conclusion that there was no difference in postoperative functional recovery following
TKA for the MSB or PAI groups. Similar to our study, Moghtadeai et al.79 randomized
40 patients to receive single injection FNB or PAI after TKA. They measured the time to
first mobilization of greater than or equal to three meters following TKA and found no
significant differences between groups.
We did not expect to see a significant difference in TUG test results between the MSB
and PAI since both interventions are quadriceps sparing techniques. Further, if any
differences did exist, we would have had to complete the TUG at an earlier time point
prior to first rescue. To do this we would have needed a physiotherapist present to safely
conduct the TUG test prior to first rescue, which was not feasible. Not surprisingly, there
were no significant differences in the time to complete the TUG test in either group at
postoperative day one or discharge. Several studies have reported similar findings14,62,92.
None were able to conduct the TUG earlier than 24 hours postoperative.
There were no statistically significant differences in total opiate consumption of
oxycodone or hydromorphone at any time points up to 72 hours between groups. This
was not an unexpected finding for our study because we used it as a second rescue, which
means it is unrelated to the interventions. However, the amount of opiates consumed in
our study was lower (0-11 mg) than generally reported (8-30mg)3,41,79 because we used it
as a second rescue whereas other studies use it as their first rescue.
There was no statistically significant difference in overall nausea or pruritus between
groups. We did not expect to see any differences in postoperative side effects since the
techniques used in both interventions were essentially opiate sparing in turn reducing side
effects such as postoperative nausea, vomiting, and pruritus4–6,33. In addition, the number
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of opiates used by study patients was low since the first rescue received was a nonnarcotic (ropivacaine).
The MSB was designed to provide pain relief for the medial side of the lower leg, the
posterior, medial anterior, and lateral areas of the knee joint, and lateral thigh. The PAI is
a local infiltration of the deep tissues of the knee and is not as site specific. Therefore, we
assumed most patients would complain of pain around the front and slightly above of the
knee joint prior to first rescue. After their first rescue we expected study patients to also
complain of pain at the back of the knee since the continuous ACB (first rescue) does not
provide analgesia for that region. We did think that if there were any differences between
groups and the location of pain, that these differences would be observed while the PAI
was wearing off but prior to first rescue. From immediate postoperative up to 6 hours
postoperative, there was no site of predominant pain; patients reported very little pain. As
expected, from six hours postoperative until discharge patients indicated that the front of
the knee was the most painful. This observation was the same for both groups even over
time, which is most likely related to the placement of the tourniquet and surgical area not
to the intervention. No other studies evaluating ACBs or PAI as interventions have
reported the site of predominant pain in patients during the postoperative period.
As expected, we did not find any statistically significant differences between groups for
the WOMAC or SF-12 questionnaires since the interventions used in our study exhibit
their greatest influence on pain and function in the immediate postoperative period
following TKA up to discharge. We were able to show that patients who received the
MSB or PAI improved their scores over the duration of the study for pain, stiffness,
general health, and functionality with no differences between groups. This finding was
similar to other studies (Bush et al)
At our institution, it is standard for patients to be discharged on the morning of
postoperative day two unless pain, muscle weakness, or extensive side effects are
negatively affecting the patient. Our results showed no statistically significant difference
between groups in length of stay(LOS) which was expected since both interventions have
their greatest influence on pain during the early postoperative period. This finding is
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consistent with other studies3,13,14. Overall NRS satisfaction with pain control at discharge
was not significantly different between groups. We also recorded satisfaction using the
satisfaction section on the KSS questionnaire. There were no significant differences
between groups at discharge or three months. This is consistent with the literature1,13,79.
Strengths of our study include the randomization of patients to intervention reducing the
chance of selection bias. We were also able to blind the patient, clinicians and outcome
assessor reducing expectation and performance biases. Our study is also the first to assess
the MSB (a modified ACB) for postoperative analgesia following TKA. It is the first
study to measure duration of analgesia for ACBs and it is the first study to compare
ACBs to PAIs.

6.1   Study  Limitations  
Limitations existed in this study including the small sample size, the start and stop time
points of the duration assessment, and the timing of the TUG test assessment.
This was a preliminary analysis since some study patients had not reached the three
month outcome assessments. When total study follow-up is complete, this will provide us
with further certainty for these results. Furthermore, a number of outcomes were
continually assessed as patients were discharged or up until first rescue. This caused
smaller sample sizes for certain outcome time points, and therefore a larger sample size
would improve precision.
By using pain greater than or equal to six as the end time for the duration assessment, we
could of prolonged the duration calculation of both interventions. Patients could of have
been in postoperative pain but had not received the rescue because their pain had not
reached six, a level that patients can interpret differently. Instead, the end time could have
been whenever a patient first felt they needed a rescue. Furthermore, we could of started
timing the duration of analgesia in both interventions immediately after surgery instead of
at two different times. This could eliminate the possible advantage of two to three hours
in duration that the MSB group might have experienced since this intervention was
completed prior to surgery.

73

Lastly, patients performed the TUG test on the morning of postoperative day one during
their first physiotherapy appointment. By this time, majority of study patients had already
received the continuous ACB because of severe pain. Therefore, our TUG test results are
not indicative of the mobility ability of patients who exclusively received the PAI or
MSB. Assessing the TUG test time earlier around six to eight hours postoperative would
have been more effective.
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Chapter  7  

7  

Conclusion  

The motor sparing block provides significantly longer duration of analgesia than the
periarticular infiltration while preserving muscle function and not negatively affecting
length of stay, satisfaction, side effects, or functional rehabilitation.

7.1   Clinical  Relevance  
Our overall goal is to develop a catheter-free intervention to manage postoperative pain
that will reduce adverse events like infections, reduce institutional costs, improve ease of
mobility, and offer a less technologically demanding option for pain management. This
study is the first step toward achieving this goal by demonstrating that the MSB offers
similar pain control to a PAI, which has been shown to be similar to the FNB. We were
also able to confidently demonstrate that the MSB preserves muscle function similar to
the PAI and better than the FNB. And finally, we were able to show that the MSB lasts
longer than the PAI. Our next step will be to add an adjuvant medication to the MSB to
prolong the analgesic effects long enough to avoid the catheter required for the usual first
rescue.

7.2   Future  Direction  
We will complete data collection for the three month outcomes of our remaining patients.
This will improve the precision of our results for these outcomes. We will also evaluate
whether there are significant differences in institutional costs between treatment groups.
Future directions should assess whether the addition of Dexemedetomidine as an
adjuvant to the anaesthetic mixture of the motor sparing knee block can prolong the
duration of analgesia and reduce the need for a catheter dependent continuous block as
the first rescue. Furthermore, future studies should assess mobilization with the TUG test
at earlier time points. This would provide an accurate assessment of the postoperative
mobilization ability of the MSB in comparison to the PAI.
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